Cell Counting Kit-8 (CCK-8)
目录号 : GK10001细胞计数试剂盒-8(CCK-8)是一种即用型的单瓶溶液,可快速、可靠地测量各种化学物质对细胞存活率和毒性的敏感度。
Sample solution is provided at 25 µL, 10mM.
- Adv Mater (2023):2307193.PMID:37951210
- Adv Mater (2024):2401538.PMID:38738793
- Adv Mater (2025):2413968.PMID:40223457
- Nat Microbiol (2025):1-16.PMID:39825096
- Adv Fiber Mater (2025):1-17.
- Cell Host Microbe 32.12 (2024):2195-2211.PMID:39610253
- Bioact Mater 51 (2025):825-840.PMID:40678266
- Brain Behav Immun 110 (2023):60-79.PMID:36754245
- Adv Sci 7.9 (2020):1902938.PMID:32382476
- Adv. Fiber Mater. (2025):1-17.
- Nat Commun 15.1 (2024):3771.PMID:38704377
- Matter (2025).
- Cancer Res 85.20 (2025).PMID:40729488
- Nat Commun 14.1 (2023):3877.PMID:37391428
- Nat Commun 15.1 (2024):72.PMID:38167723
- Cancer Res (2025).PMID:40729488
- Trends in Sciences 22.9 (2025):10417-10417.
- ACS nano 17.7 (2023):7017-7034.PMID:36971310
- ACS nano (2025).PMID:39846120
- Nat Commun 16.1 (2025):6271.PMID:40623997
- Nat Commun 16.1 (2025):7650.PMID:40819125
- Acs Nano (2024).PMID:39361472
- Nat Commun 16.1 (2025):6532.PMID:40664636
- Nat Commun 16.1 (2025):6807.PMID:40707439
- Acs Nano 19.35 (2025):31656-31676.PMID:40878028
- Nat Commun 16.1 (2025):6100.PMID:40603843
- Nat Commun 16.1 (2025):7827.PMID:40846845
- Cancer Commun (2024).PMID:38512764
- Acs Nano (2025).PMID:40534228
- Nat. Commun. 16.1 (2025):7856.PMID:40846856
- Autophagy 18.5 (2022):1049-1061.PMID:34517786
- Acs Nano (2025).PMID:40878028
- Acta Pharm Sin B (2025).
- Adv Sci (2023):2301107.PMID:37097746
- Acta Pharm Sin B (2025).
- Brain Behav Immun (2024).PMID:38565398
- Cancer Commun 43.5 (2023):582-612.PMID:37005481
- Nat Commun 16.1 (2025):3605.PMID:40240371
- Nat. Commun. 16.1 (2025):2551.
- Adv-Sci 10.27 (2023):2302640.PMID:37485650
- Autophagy just-accepted (2024).PMID:39007910
- Acta-Pharm-Sin-B-(2025).
- Adv Sci 10.31 (2023):2301120.PMID:37688357
- Adv Sci (2024):2401845.PMID:38757623
- Adv Sci (2025):e04192.PMID:40536697
- Sci Adv 10.10 (2024):eadg7380.PMID:38457499
- Adv Sci (2025):e08742.PMID:41340222
- Adv Sci (2024):2404365.PMID:39159143
- Adv Sci (2025):2417374.PMID:40213972
- Microbiome 12.1 (2024):152.PMID:39152482
- Adv Sci (2024):2402450.PMID:38952061
- Adv Sci (2025):e08503.PMID:40685704
- Advanced Science (2025):e08503.PMID:40685704
- Adv Sci (2025):2417374.PMID:40213972
- Adv Sci (2025):e02781.PMID:40886326
- Adv Sci (2025):2417318.PMID:40472230
- Adv Sci (2025):2413936.PMID:40047320
- Biomaterials (2025):123335.PMID:40222258
- Biomaterials 325 (2026):123539.PMID:40664088
- Small (2024):2407674.PMID:39363789
- J Adv Res (2023).PMID:36933884
- J Nanobiotechnol (2025).PMID:40691611
- Emerg Microbes Infec 12.1 (2023):2204164.PMID:37060263
- Theranostics 15.14 (2025):6919.PMID:40585994
- J Adv Res 8.3 (2025):132-137.
- Water Res (2024):121379.PMID:38422694
- Small 21.3 (2025):2409121.PMID:39544127
- Microbiome 13.1 (2025):1-19.PMID:41063317
- J Nanobiotechnol 23.1 (2025):643.PMID:41074154
- J Adv Res (2025).PMID:40373960
- J Exp Clin Canc Res 44.1 (2025):193.PMID:40616124
- J Nanobiotechnol 23.1 (2025):537.PMID:40707955
- Science Advances 11.31 (2025):eadx6732.PMID:40737412
- Exp Mol Med (2025):1-15.PMID:40887495
- Theranostics 15.15 (2025):7802.PMID:40756352
- Nano Today 61 (2025):102560.
- Biomaterials (2025):123539.PMID:40664088
- Sci Adv 11.33 (2025):eadx3851.PMID:40802748
- Carbohyd Polym (2025):124445.
- Theranostics 15.15 (2025):7820.PMID:40756354
- Theranostics 15.15 (2025):7802.PMID:40756352
- J Exp Clin Canc Res 41.1 (2022):293.PMID:36199122
- J Nanobiotechnol 23.1 (2025):533.PMID:40691611
- J Med Virol 95.10 (2023):e29171.PMID:37830751
- J Exp Clin Canc Res 44.1 (2025):193.PMID:40616124
- Mater Horiz (2024).PMID:39189308
- Redox Biol (2025):103771.PMID:40669208
- Mol Ther (2025).PMID:39810420
- Mol. Ther. 33.3 (2025):1134.PMID:39810420
- Redox Biol (2025):103870.PMID:41101210
- J Control Release (2025):114187.PMID:40902670
- Redox Biology (2025):103870.
- Mater Horiz (2024).PMID:39189308
- Small Methods (2024):2400223.PMID:38602202
- Gut Microbes 16.1 (2024):2347757.PMID:38773738
- Theranostics 12.7 (2022):3488.PMID:35547749
- Theranostics 14.16 (2024):6161.PMID:39431016
- Cell Death Differ 30.10 (2023):2293-2308.PMID:37608075
- Engineering-Prc (2025).
- Gut Microbes 17.1 (2025):2446376.PMID:39718561
- J Hazard Mater (2024):135904.PMID:39303616
- J Immunother Cancer 12.3 (2024):e008054.PMID:38429070
- J Exp Clin Canc Res 43.1 (2024):187.PMID:38965580
- EBioMedicine 99 (2024).PMID:38101299
- Medcomm 6.9 (2025):e70365.PMID:40919132
- Clin Transl Med 14.1 (2024):e1539.PMID:38224186
- Acta Biomater 157 (2023):321-336.PMID:36481504
- J Control Release 360 (2023):647-659.PMID:37406817
- Cardiovascular Diabetology 24.1 (2025):338.PMID:40826463
- Research-China 8 (2025):0823.PMID:40822127
- Environmental Science & Technology (2025).PMID:40743993
- Cell Discov 6.1 (2020):96.PMID:33349633
- Research 8 (2025):0854.PMID:40927753
- Research 8 (2025):0860.PMID:40862056
- Sci Total Environ 878 (2023):162942.PMID:36940749
- Environ Sci Technol (2025).PMID:40743993
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- Research-China (2025).
- Water Res (2024):122403.PMID:39278116
- Redox Biol 62 (2023):102663.PMID:36924682
- Cell Rep Med 6.9 (2025).PMID:40961922
- Environ Sci Technol (2024).PMID:39364562
- J Exp Clin Canc Res 39 (2020):1-13.PMID:32028978
- J Adv Res (2025).PMID:40373960
- J Control Release 359 (2023):12-25.PMID:37244298
- J Control Release 365 (2024):301-316.PMID:38007195
- Environ Sci Technol 56.21 (2022):15096-15107.PMID:36099323
- J Control Release 373 (2024):749-765.PMID:39084465
- Cell Discov 6.1 (2020):96.PMID:33349633
- Research-China (2025).
- Redox Biol (2023):102983.PMID:38064762
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Exp Clin Canc Res 41.1 (2022):1-15.PMID:34980201
- J Adv Res (2025).
- J Exp Clin Canc Res 43.1 (2024):91.PMID:38528516
- J Control Release 379 (2025):89-104.PMID:39756690
- J Exp Clin Canc Res 44.1 (2025):1-19.PMID:40069844
- J Control Release 349 (2022):254-268.PMID:35803328
- Research 8 (2025):0854.PMID:40927753
- Environ Health Persp 131.6 (2023):067004.PMID:37267060
- Sci Total Environ 897 (2023):165514.PMID:37451464
- Cell Death Dis 16.1 (2025):763.PMID:41145422
- Rare Met. (2025):1-23.
- Acta Biomater (2025).PMID:40946735
- Adv Healthc Mater (2025):2500845.PMID:40400499
- Mater Today-Bio (2025):102420.
- Mater Today Bio (2025):102288.
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Cell Death Dis 16.1 (2025):502.PMID:40624028
- Adv Healthc Mater 12.9 (2023):2202785.PMID:36541060
- J Immunother Cancer 13.6 (2025):e011717.PMID:40473272
- Mater Today Bio (2025):102288.PMID:40978162
- J Nanobiotechnol 21.1 (2023):354.PMID:37775761
- Food Chem (2025):146103.PMID:18830861
- Acta Biomater (2024).PMID:38452962
- J Nanobiotechnol 23.1 (2025):1-22.PMID:39871272
- Mater Today Bio 32 (2025):101703.PMID:40230646
- Adv Healthc Mater (2024):2401061.PMID:38849128
- Adv Healthc Mater (2025):e01742.PMID:40751487
- Adv Healthc Mater 11.8 (2022):2102395.PMID:34874119
- Cell Death Dis 16.1 (2025):502.PMID:40624028
- Pharmacol Res 187 (2023):106563.PMID:36410674
- Cell Death Dis 16.1 (2025):634.PMID:40841355
- Cell Death Dis (2025):680.PMID:41053142
- Cancer Lett 620 (2025):217685.PMID:40158720
- Cell Death Dis 16.1 (2025):493.PMID:40615369
- J Nanobiotechnol 22.1 (2024):1-15.PMID:38790037
- J Neuroinflamm 20.1 (2023):1-16.PMID:36944954
- J Nanobiotechnol 22.1 (2024):1-21.PMID:38448959
- Mater Today Bio (2025):102652.
- ENGINEERING-PRC (2025).
- Adv Healthc Mater (2025):e02762.PMID:41070830
- Cardiovasc Res 121.2 (2025):324-338.PMID:39658102
- Adv Healthc Mater 13.8 (2024):2303215.PMID:38112062
- Adv Healthc Mater (2024):2402877.PMID:39434433
- Cancer Lett (2025):218156.PMID:41265630
- Int J Biol Sci 22.1 (2026):142-160.PMID:41362747
- Mater Today Bio (2025):101901.PMID:40520551
- J Immunother Cancer 12.10 (2024):e009416.PMID:39455095
- View-China (2025):20240103.
- Cell Death Dis 16.1 (2025):833.PMID:41249119
- Biomater Res 29 (2025):0286.PMID:41293090
- Cell Mol Biol Lett 30.1 (2025):139.PMID:41249917
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Cancer Lett (2024):216765.PMID:38408604
- Cell Mol Life Sci 79.7 (2022):382.PMID:35751755
- Int J Biol Macromol (2025):149301.PMID:41330503
- Acta Biomater (2025).PMID:40024424
- Mol Ther-Nucl Acids 31 (2023):703-716.PMID:36923951
- ACS Appl Mater Inter 14.13 (2022).PMID:35344348
- Front Immunol 14 (2023):1130308.PMID:37006248
- Pharmacol Res 180 (2022):106225.PMID:35452801
- Cell Mol Biol Lett 29.1 (2024):103.PMID:38997648
- Genes Dis (2025):101732.PMID:37815978
- Environ Pollut 338 (2023):122581.PMID:37748638
- Cell Death Dis 13.5 (2022):497.PMID:35614040
- Cancer Lett 611 (2025):217418.PMID:39725146
- Food Chem (2024):139505.PMID:38703732
- Acta Biomater 113 (2020):393-406.PMID:32629189
- J Colloid Interf Sci (2025):.PMID:39755016
- Cell Mol Life Sci 80.3 (2023):61.PMID:36763212
- Biomark Res 11.1 (2023):3PMID:36611218
- Environ Pollut 334 (2023):122148.PMID:37419204
- Int J Biol Macromol (2025):146723.PMID:40784392
- Pharmacol Res 195 (2023):106877.PMID:37524154
- Acta Biomater (2025).PMID:39952883
- Mater. Today Bio (2025):101703.
- Liver Int 43.4 (2023):840-854.PMID:36737842
- Cancer Lett (2024):217418.PMID:39725146
- CANCER LETT (2025):217685.
- Brit J Cancer (2024):1-9.PMID:38594370
- Pharmacol Res (2024):107460.PMID:39393436
- Acs Appl Mater Inter (2024).PMID:38345297
- Acs Appl Mater Inter 15.11 (2023).PMID:36897565
- Cell Death Dis 13.10 (2022):858.PMID:36209201
- Acs Appl Mater Inter 15.32 (2023).PMID:37542453
- J Colloid Interf Sci (2025):137652.
- Phytomedicine (2025):157658.
- Int J Biol Macromol (2024):135562.PMID:39276884
- Phytomedicine (2025):157371.
- Int J Biol Macromol 306 (2025):141410.PMID:40010477
- Acs Appl Mater Inter (2025).PMID:40025657
- Phytomedicine 122 (2024):155091.PMID:37844378
- Free Radical Bio Med (2025).PMID:40782974
- Free Radical Bio Med (2025).PMID:40782974
- Int J Biol Macromol (2025):148198.PMID:41072677
- Int J Biol Macromol (2025):147167.PMID:40889659
- Npj Precis Oncol 9.1 (2025):269.PMID:40753128
- Cell Mol Biol Lett 29.1 (2024):83.PMID:38822277
- Mater Today Bio (2024):101019.PMID:38516170
- Int J Biol Macromol (2025):140374.PMID:39880265
- Int J Biol Macromol (2024):137561.PMID:39537068
- Cell Commun Signal 22.1 (2024):293.PMID:38802896
- Cell Mol Life Sci 81.1 (2024):143.PMID:38493426
- Int J Biol Macromol (2025):140632.PMID:39909240
- Acs Appl Mater Inter (2025).PMID:39853325
- Cell Commun Signal 22.1 (2024):1-19.PMID:38454413
- Int J Biol Macromol (2024):131928.PMID:38688339
- Int J Biol Sci 21.4 (2025):1837-1851.
- Acs Appl Mater Inter (2024).PMID:39448903
- Acs Sensors (2024).PMID:38958530
- Oncogene (2023):1-13.PMID:37138031
- Int J Biol Macromol (2025):145368PMID:40541884
- Free Radical Bio Med 188 (2022):404-418.PMID:35787451
- Int J Biol Macromol (2025):148033.PMID:41038469
- Int J Biol Macromol 224 (2023):797-809.PMID:36283555
- Int J Biol Macromol (2025):141146.PMID:39986528
- Phytomedicine 118 (2023):154944.PMID:37393830
- Sci Rep-Uk 15.1 (2025):1-16.PMID:40436970
- Cell Death Dis 16.1 (2025):240.PMID:40175350
- Phytomedicine (2025):157402PMID:41101069
- Int Immunopharmacol 158 (2025):114885.PMID:40383096
- Front Immunol 16 (2025):1569210.PMID:40396173
- Food Res Int 204 (2025):115940.PMID:39986784
- Cell Mol Life Sci 81.1 (2024):32.PMID:38214780
- View:20250139.
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Sci 21.2 (2025):614.PMID:39781455
- CANCER IMMUNOL RES (2025).PMID:40323348
- Cell Death Dis 12.4 (2021):408.PMID:33859186
- Int J Biol Macromol (2024):133667.PMID:38969038
- Sci Rep-Uk 15.1 (2025):1-14.PMID:40450025
- Phytomedicine (2025):157435.PMID:41177014
- Int J Biol Macromol(2023):125130.PMID:37263336
- Cell Death Dis 12.8 (2021):779.PMID:34365463
- Int. J. Biol. Markers (2025):143683.PMID:40318724
- Int. J. Biol. Macromol. (2025):143759.
- INT J BIOL SCI 21.7 (2025):3099-3121.
- Int J Biol Macromol (2024):136818.PMID:39447809
- Int. J. Biol. Macromol. (2025):142238.PMID:40112979
- Int J Biol Macromol (2024):129172.PMID:38176496
- Biomater Sci-UK 10.17 (2022):5006-5017.PMID:35815806
- Int J of Bio Macromol (2024):132103.PMID:38719011
- Nanoscale Horiz (2025).
- Phytomedicine (2023):155270.PMID:38096717
- Sci Rep-Uk 15.1 (2025):1-17.PMID:40383858
- Cell Death Dis 13.3 (2022):233.PMID:35288538
- iol Macromol (2025):148610.PMID:41177487
- Cell Commun Signal 22.1 (2024):1-23.PMID:39696352
- Mater Today Bio (2025):101901.
- Acta Pharmacol. Sin. (2025):1-13.PMID:40903541
- Int J Biol Macromol (2025):147767.PMID:40972920
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- Int J Biol Macromol (2025):141767.
- Sci China Life Sci (2025):1-11.PMID:39821161
- Int J Biol Macromol 222 (2022):1789-1800.PMID:36191790
- Acs Omega (2025).
- Environ Res (2024):118221.PMID:38246300
- Acs Appl Mater Inter (2024).PMID:39320506
- Int J Biol Macromol (2025):140602.PMID:39922352
- Antivir Res 205 (2022):105381.PMID:35835291
- Int J Biol Macromol (2024):135979.PMID:39332550
- Int J Biol Macromol 220 (2022):371-384.PMID:35970372
- Phytomedicine (2025):157223.PMID:40929882
- Free Radical Bio Med 190 (2022):202-215.PMID:35985562
- Biomed Pharmacother 122 (2020):109690.PMID:31786468
- Ecotox Environ Safe 280 (2024):116579.PMID:38865940
- Biomed Pharmacother 168 (2023):115751.PMID:37879214
- J Med Chem 65.4 (2021):2794-2808.PMID:33872498
- J Cell Physiol 238.1 (2023):195-209.PMID:36436184
- Cell Death Discov 10.1 (2024):7.PMID:38182573
- Clin Epigenetics 14.1 (2022):1-12.PMID:35414117
- J Med Virol 96.11 (2024):e70049.PMID:39558699
- J Mater Chem B 11.16 (2023):3740-3751.PMID:37067505
- J Environ Chem Eng 13.3 (2025):116286.
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Phytother Res (2024).PMID:38558449
- Ecotox Environ Safe 270 (2024):115813.PMID:38113798
- Diabetes (2025):db250132.PMID:40906541
- Ecotox Environ Safe 262 (2023):115161.PMID:37356398
- Phytomedicine (2024):155859.PMID:38972239
- Front Cell Dev Biol 9 (2021):696558.PMID:34447749
- Oncogenesis 11.1 (2022):21.PMID:35487890
- Int J Nanomed (2024):13183-13199.PMID:39664759
- Int J Nanomed 20 (2025):293-308.
- J Anim Sci Biotechno 16.1 (2025):121.PMID:40887645
- Food Res Int (2025):115940.
- Biomed Pharmacother 130 (2020):110566.PMID:32755793
- Life Sci 312 (2023):121092.PMID:36279968
- Life Sci 308 (2022):120925.PMID:36057399
- Wirel Commun Mob Com 2 (2022):3.PMID:36120596
- Front Cell Dev Biol 10 (2022):850708.PMID:35592246
- Oncogene (2025):1-15.PMID:39920289
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Phytomedicine 130 (2024):155744.PMID:38763011
- Stem Cell Res Ther 16.1 (2025):239.PMID:40361250
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Bba-Mol Basis Dis 1869.1 (2023):166571.PMID:36244542
- Food Chem Toxicol 148 (2021):111972.PMID:33421461
- Cell Death Discov 9.1 (2023):415.PMID:37968255
- Biomed Pharmacother 174 (2024):116470.PMID:38565061
- Mater Today Bio 15 (2022):100264.PMID:35517578
- Front Cell Dev Biol 9 (2021):749210.PMID:34676217
- Arch Toxicol (2025):1-17.PMID:40464975
- J Med Chem (2025).PMID:39842821
- Nanoscale 16.17 (2024):8479-8494.PMID:38590261
- J Polym Environ (2025):1-16.
- Phytomedicine (2025):156598.
- J Med Chem (2024).PMID:38315032
- J Gastroenterol (2023):1-14.PMID:37150773
- Biomed Pharmacother 177 (2024):117037.PMID:38959602
- Fertil Steril (2023).PMID:37178109
- J Med Virol 97.3 (2025):e70267.
- Appl Mater Today 47 (2025):102949.
- Bba Mol Basis Dis 1869.7 (2023):166725.PMID:37127173
- Biomed Pharmacother 165 (2023):115261.PMID:37549461
- Phytomedicine (2025):156860.
- J Med Chem (2024).PMID:39292661
- Cell Death Discov 11.1 (2025):549.PMID:41315223
- Biomed Pharmacother 129 (2020):110315.PMID:32554246
- Front Immunol 14 (2023).PMID:37662906
- Cell Death Discov 11.1 (2025):1-12.PMID:40456746
- Chem-Biol Interact (2025):111576.PMID:40456372
- Inflamm Res 74.1 (2025):1-22.PMID:40439750
- Cell Death Discov 11.1 (2025):1-16.PMID:40399275
- Eur J Med Chem 238 (2022):114458.PMID:35635946
- Stem Cell Res Ther 15.1 (2024):1-18.PMID:39267160
- Npj Precis Oncol 9.1 (2025):112.PMID:40240582
- Embo Rep (2025):1-23. PMID:40185977
- Antioxidants-Basel 14.8 (2025):915.PMID:40867814
- J. Environ. Chem. Eng. (2025):116286.
- Int J Nanomed (2025):11295-11314.PMID:40989888
- AGING DIS 17.1 (2026):2.PMID:40072367
- Brit J Pharmacol (2024).PMID:38715438
- Cell Death Discov 10.1 (2024):97.PMID:38402198
- Int J Nanomed (2025):4535-4550.PMID:4023652
- Arch Pharm Res (2025):1-21.PMID:41258371
- Stem Cell Res Ther 16.1 (2025):1-18.PMID:40361250
- Antioxid Redox Sign 37.13 (2022):867-886.PMID:35350885
- Virol Sin (2023).PMID:37331658
- Stem Cell Res Ther 15.1 (2024) 385.PMID:39468662
- Anal Chem 95.31 (2023):11664-11671.PMID:37495553
- Phytother Res 37.10 (2023):4639-4654.PMID:37394882
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Mater Today Chem 50 (2025):103156.
- Stem Cell Res Ther 10.1 (2019):1-14.PMID:31847890
- Iscience (2025).
- Front Immunol 13 (2022):986214.PMID:36341437
- Front Immunol 13 (2022):902515.PMID:35874682
- Biomed Pharmacother 188 (2025):118217.PMID:40435839
- Acta Pharmacol Sin (2025):1-15.PMID:39984622
- Oncogene (2025):1-17.PMID:40968253
- Int J Nanomed (2025):11295-11314.PMID:40989888
- Neural Regen Res (2025):10-4103.PMID:41017682
- Neural Regen Res (2025):10-4103.PMID:41017725
- J Med Chem 68.3 (2025):3356-3372.PMID:39842821
- Front Immunol 14 (2023):1111494.PMID:36817451
- Plos Pathog 17.3 (2021):e1009393.PMID:33684175
- Biomed Pharmacother 158 (2023):114118.PMID:36527845
- Cell Death Discov 11.1 (2025):427.PMID:41052997
- Cell Biol Toxicol 38.6 (2022):1121-1136.PMID:35348966
- Bioeng Transl Med 8.3 (2023):e10475.PMID:37206234
- Phytomedicine (2025):156515.PMID:39983438
- Plos Pathog 19.10 (2023):e1011702.PMID:37801439
- Biomed Pharmacother 179 (2024):117415.PMID:39265236
- Biomed Pharmacother 189 (2025):118248.PMID:40561593
- Phytomedicine (2025):156928.
- Free Radical Bio Med (2024).PMID:38367927
- J Med Chem (2025).PMID:40500735
- Cell Rep 44.3 (2025).PMID:39977268
- Antioxidants-Basel 14.8 (2025):915.
- Biomed Pharmacother 184 (2025):117907.PMID:39978030
- Ecotox Environ Safe 266 (2023):115571.PMID:37837696
- Biomed Pharmacother 162 (2023):114602.PMID:37018993
- Front Nutr 9 (2022):812623.PMID:35419394
- Emerg Microbes Infec (2025):2522877.PMID:40536397
- Cancer Cell Int 21 (2021):1-12.PMID:34281530
- J Agr Food Chem 73.14 (2025).PMID:40152883
- Aging (Albany NY) 13.17 (2021):21712.PMID:34518442
- Mol Ther Nucl Acids (2025).
- Bba-Mol Basis Dis (2024):167210.PMID:38704001
- Front Bioeng Biotech 12 (2024):1361682.PMID:38562665
- Mol Neurobiol 58 (2021):1990-2004.PMID:33411316
- Front Oncol 12 (2022):770628.PMID:35372056
- Cancer Gene Ther 29.8-9 (2022):1228-1239.PMID:35115683
- Cancer Gene Ther (2021)1-12.PMID:33888871
- Cancer Cell Int 24.1 (2024):123.PMID:38566075
- J Mater Chem B(2025).PMID:41235444
- Int J Mol Sci 22.21 (2021):11893.PMID:34769322
- J Gastroenterol (2025):1-17.PMID:41060436
- Int Immunopharmacol 132 (2024):111870.PMID:38547771
- Cancer Cell Int 20 (2020):1-14.PMID:33292221
- Mol Med 30.1 (2024):14.PMID:38254010
- Cell Mol Life Sci 81.1 (2024):265.PMID:38880863
- Am J Physiol-Cell Ph (2024).PMID:38525543
- Acs Biomater Sci Eng (2024).PMID:38445959
- Aging (Albany NY) 13.3 (2021):4482.PMID:33495411
- Int Immunopharmacol 131 (2024):111922.PMID:38522137
- Molecular Therapy Oncology 32.2 (2024).PMID:38948919
- Front Pharmacol 12 (2021):673263.PMID:34108880
- Acs Biomater Sci Eng (2024).PMID:38446137
- Phytother Res (2025).PMID:41253721
- J Nutr Biochem (2024):109678.PMID:38844080
- Lab Invest 102.4 (2022):411-421.PMID:34775495
- Dent Mater (2025).PMID:41152035
- Front Oncol 12 (2022):858598.PMID:35321435
- Front Pharmacol 12 (2021):610158.PMID:33762939
- Ecotox Environ Safe 233 (2022):113315.PMID:35189521
- Life Sci (2024):122483.PMID:38307238
- Biochem Pharmacol (2024):116044.PMID:38336157
- Am J Chinese Med (2024):1-23.PMID:38490807
- Aging (Albany NY) 16.11 (2024):9625.PMID:38829771
- Front Pharmacol 12 (2021):649398.PMID:34335241
- Front Immunol 16 (2025):1569210.
- Front Pharmacol 13 (2022):927488.PMID:35935870
- Front Pharmacol 13 (2022):1043022.PMID:36588728
- J Invest Dermatol (2025).PMID:39892773
- Front Cell Dev Biol (2023):1161541.PMID:37325570
- BREAST CANCER RES 27.1 (2025):61.PMID:40270028
- Int J Pharmaceut (2023):123142.PMID:37328119
- Am J Cancer Res 13.5 (2023):2135.PMID:37293170
- Int Immunopharmacol 121 (2023):110413.PMID:37301119
- Liver Int 45.2 (2025):e16246.PMID:39821525
- Front Oncol 13 (2023):1132424.PMID:37251940
- Apoptosis (2025):1-17.PMID:40347321
- Microbiol Res (2024):127927.PMID:39393129
- Phytother Res (2023).PMID:37246830
- Microbiol Res (2025):128183.
- Biochem Pharmacol 213 (2023):115592.PMID:37196680
- Int J Mol Med 54.6 (2024):1-17.PMID:39364745
- Front Immunol 15 (2024):1455996.PMID:39376562
- Int J Mol Sci 23.24(2022):16045.PMID:36555684
- Front Immunol 15 (2024):1375781.PMID:39391314
- Mol Med 31.1 (2025):1-15.PMID:40369420
- Int J Mol Med 55.3 (2025):45.PMID:39791203
- Front Pharmacol 11 (2020):16.PMID:32140106
- Int J Mol Med 55.3 (2025):1-17.
- Mol Med 31.1 (2025):1-15.PMID:40405066
- Antioxid Redox Sign (2025).PMID:40455659
- Ecotox Environ Safe 287 (2024):117331.PMID:39547060
- Neurotoxicol Teratol (2025):107500.PMID:40456500
- Biomater Adv (2024):214069.PMID:39447240
- J Agr Food Chem 71.1 (2022):546-556.PMID:36538589
- Phytother Res (2023).PMID:37086359
- J Agr Food Chem (2025).PMID:40152883
- Biomater Adv (2025):214257.PMID:40023084
- Front Pharmacol 13 (2022):819826.PMID:35645824
- Front Pharmacol 13 (2022):965131.PMID:36249790
- J Agr Food Chem (2025).PMID:40017402
- Front Cell Dev Biol 10 (2022):787730.PMID:35445026
- Mol Cell Proteomics (2025):100930.PMID:40024376
- J Agr Food Chem (2025).PMID:39962827
- Front Immunol 15 (2024):1455996.PMID:39376562
- Front Pharmacol 13 (2022):972397.PMID:36188529
- Cells 11.23 (2022):3816.PMID:36497076
- Cancer Cell Int 23.1 (2023):142.PMID:37468908
- Mar Life Sci Tech 4.3 (2022):373-383.PMID:37073164
- Front. Immunol. 16 (2025):1556715.
- J Transl Med 23.1 (2025):131.PMID:39885513
- Talanta (2025):127591.PMID:39847915
- Biomacromolecules (2025).
- Front Immunol 16 (2025):1521965.PMID:40191190
- Biochem Pharmacol (2023):115632.PMID:37263300
- Cns Neurosci Ther (2023).PMID:37452510
- J Invest Dermatol (2025).PMID:39892773
- MOL MED 31.1 (2025):126.PMID:40186145
- Phytother. Res. 39.3 (2025):1355-1371.PMID:39764683
- Aging (Albany NY) 15.12 (2023):5673.PMID:37387540
- Front Immunol 15 (2024):1455996.PMID:39376562
- Front Oncol 12 (2022):858598.PMID:35321435
- Front Pharmacol 13 (2022):1015693.PMID:36210855
- Front Immunol 15 (2024):1375781.PMID:39391314
- Front Pharmacol 14 (2023):1168393.PMID:37124212
- Cell Death Discov 11.1 (2025):74.PMID:39988672
- Faseb J 37.5 (2023):e22935.PMID:37086094
- Mol Med 30.1 (2024):1-18.PMID:39266965
- Int Immunopharmacol 113 (2022):109342.PMID:36327871
- Front Oncol 13 (2023):1120103.PMID:36959804
- Mbio (2023):e01688-23.PMID:37882780
- J Transl Med 22.1 (2024):1-19.PMID:39107788
- Exp Neurol 359 (2023):114266.PMID:36336032
- Apoptosis 28.3-4 (2023):414-431.PMID:36482019
- J Agr Food Chem 70.50 (2022):15763-15775.PMID:36472370
- Apoptosis (2024):1-19.PMID:39097858
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Front Cell Dev Biol 9 (2022):793793.PMID:35155447
- J Agr Food Chem (2023).PMID:37922022
- Front Immunol 16 (2025):1619733.PMID:40842984
- Int J Mol Med 55.3 (2025):1-14.PMID:39791203
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Cells 11.24 (2022):4094.PMID:36552856
- Ecotox Environ Safe 289 (2025):117511.PMID:39662457
- Front Pharmacol 13 (2022):946193.PMID:36091823
- Int J Mol Sci 24.22 (2023):16503.PMID:38003694
- Biomolecules 12.9 (2022):1283.PMID:36139122
- Mol Neurobiol 59.12 (2022):7075-7094.PMID:36083519
- Int J Mol Sci 23.22 (2022):14306.PMID:36430782
- Acs Biomater Sci Eng (2025).PMID:40891613
- J Agr Food Chem (2025).PMID:40899763
- J Enzym Inhib Med Ch 39.1 (2024):2288810.PMID:38059334
- Lab Chip (2024).PMID:38939907
- Jci Insight (2024). PMID:38935435
- Mol Med 30 (2024):260.PMID:39707194
- Mol Med 31.1 (2025):258.PMID:40681992
- Phytother Res (2025).PMID:40675558
- Chinese Med J-Peking 136.05 (2023):556-564.PMID:36939243
- J Agr Food Chem 71.3 (2023):1593-1606.PMID:36634077
- Mol Med 31.1 (2025):200.PMID:40405066
- Chinese Med J-Peking (2023):10-1097.PMID:36939243
- Eur J Pharm Biopharm 188 (2023):89-99.PMID:36702198
- Jci insight 9.15 (2024):PMID:38935435
- Int-Immunopharmacol 124 (2023):110809.PMID:37690240
- Cell Biosci 15.1 (2025):95.PMID:40615893
- J Mater Chem B (2024).PMID:39119756
- Front Immunol 16 (2025):1618342.
- J Transl Med 22.1 (2024):1-17.PMID:39267037
- Mol Med 31.1 (2025):188.PMID:40369420
- Resp Res 24.1 (2023):216.PMID:37674165
- Stem Cell Transl Med (2024):szae020.PMID:38530131
- Front Immunol 16 (2025):1591912.PMID:40655141
- Int J Mol Med 55.4 (2025):1-16.PMID:39918010
- Colloid Surface B 222 (2023):113119.PMID:36621177
- J Transl Med 22.1 (2024):1-15.PMID:39256832
- Front Immunol 16 (2025):1591912.
- J Ethnopharmacol 310 (2023):116375.PMID:36934787
- J Neurochem 164.5 (2023):643-657.PMID:36527420
- J Oncol 2022 (2022).PMID:36281290
- J Oncol 2022 (2022).PMID:36213838
- Microorganisms 11.5 (2023):1268.PMID:37317242
- J Oncol 2022 (2022):6459029PMID:36199788
- Molecules 27.17 (2022):5698.PMID:36080465
- Front Endocrinol 13 (2022):998971.PMID:36147560
- Front Oncol 12 (2022):996080.PMID:36483054
- Molecules 27.23 (2022):8568.PMID:36500666
- Front Endocrinol 13 (2022):657802.PMID:36263320
- Molecules 28.6 (2023):2426.PMID:36985397
- Pharmaceuticals 15.10 (2022):1271.PMID:36297383
- J Ethnopharmacol (2024):118080.PMID:38521426
- Pharmaceuticals 15.11 (2022):1435.PMID:36422564
- J Ethnopharmacol (2023):116731.PMID:37277084
- Front Oncol 12 (2022):961653.PMID:36457504
- J Cell Mol Med 26.13 (2022):3783-3796.PMID:35656815
- Front Oncol 12 (2022):1043161.PMID:36439418
- J Virol 97.11 (2023):e00719-23.PMID:37929962
- J Ethnopharmacol 307 (2023):116193.PMID:36746295
- Mol Carcinogen (2023).PMID:37750597
- Sci Rep-Uk 13.1 (2023):14339.PMID:37658227
- Int J Mol Med 52.5 (2023):1-14.PMID:37800609
- Sci Rep-Uk 13.1 (2023):361.PMID:36611103
- Am J Cancer Res 14.1 (2024):324.PMID:38323285
- Cell Signal 113 (2024):110962.PMID:37931691
- J oncol 2022 (2022).PMID:36385962
- Biotechnol J 19.1 (2024):2300453.PMID:37899497
- Mol Carcinogen 62.2 (2023):160-173.PMID:36222184
- J Oncol 2022 (2022).PMID:36213831
- Cell Signal (2023):110987.PMID:38029946
- Environ Toxicol (2023).PMID:38069587
- Aging (Albany NY) 15.23 (2023):14292.PMID:38059876
- J Ethnopharmacol 319 (2024):117091.PMID:37634753
- J Ethnopharmacol 319 (2024):117205.PMID:37741473
- Bone Joint Res 13.12 (2024):763-777.PMID:39662502
- Int Immunopharmacol 108 (2022):108742.PMID:35378447
- Diabetol Metab Syndr 16.1 (2024):1-14.PMID:38317244
- J Cell Mol Med 28.6 (2024):e18223.PMID:38451046
- Molecules 27.14 (2022):4603.PMID:35889477
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- Drug Deliv Transl Re (2023):1-13.PMID:37130996
- Bioorg Chem 136 (2023):106556.PMID:37105002
- Chem-Biol Interact 382 (2023):110638.PMID:37473910
- Burns Trauma 12 (2024):tkae001.PMID:38434722
- J Ethnopharmacol (2024):117985.PMID:38417600
- J Virol (2023):e00549-23.PMID:37222617
- J Ethnopharmacol (2024):117958.PMID:38395179
- Cell Cycle 21.8 (2022):835-850.PMID:35100080
- Acs Infect Dis 8.9 (2022):1851-1868.PMID:35948057
- J Hepatocell Carcino (2023):863-881.PMID:37313303
- Invest Ophth Vis Sci 63.6 (2022):13-13.PMID:35695808
- Cell Death Discov 8.1 (2022):85.PMID:35220396
- Eur-J Pharmacol 958 (2023):176033.PMID:37673365
- J Ethnopharmacol (2024):117865.PMID:38369066
- J Dermatol Sci 109.2 (2023):52-60.PMID:36858850
- Bioengineering 9.9 (2022):433.PMID:36134979
- Int Immunopharmacol 107 (2022):108695.PMID:35305385
- J-Ethnopharmacol (2023):116729.PMID:37277081
- Mol Neurobiol 59.8 (2022):4776-4790.PMID:35622272
- Exp Neurol (2025):115252.PMID:40221008
- Molecules 27.21 (2022):7183.PMID:36364008
- Biochem Pharmacol (2024):116438.PMID:39025409
- Pharmaceuticals-Base 18.8 (2025):1187.
- Mol Neurobiol (2025):1-16.PMID:40402409
- Mol. Nutr. Food Res. (2025):e70053.PMID:40177855
- J. Ethnopharmacol. (2025):119727.PMID:40187623
- J Am Heart Assoc (2025):e040093.PMID:40767292
- Eur J Pharmacol 998 (2025):177497.PMID:40058753
- Front Pharmacol 16 (2025):1613560.PMID:40822457
- Chem-Biol Interact (2025):111702.PMID:40812562
- Life Sci (2024):123148.PMID:39447733
- Mol Nutr Food Res (2024):2300912.PMID:38847553
- Front Toxicol 7 (2025):1598185.PMID:40376450
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- Antivir Ther 30.3 (2025):13596535251345953.PMID:40434182
- J Drug Deliv Sci Tec 107 (2025):106841.
- J Ethnopharmacol 347 (2025).PMID:40187623
- J. Drug Delivery Sci. Technol. (2025):106841.
- Arch Toxicol (2025):1-17.PMID:40464975
- Macromol Biosci (2024):2400003.PMID:38597147
- Cell Oncol (2025):1-17.PMID:41051595
- Bioorg Chem (2025):108656.
- Glia (2025).PMID:40747821
- Bioorg Chem (2025):108667.
- Nutrients 17.5 (2025):923.PMID:40077793
- Food Biosci (2025):106564.
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Invest Ophth Vis Sci 66.13 (2025).PMID:41099598
- Arch Toxicol (2024):1-16.PMID:38971901
- J Nutr Biochem (2024):109780.PMID:39395694
- Front. Pharmacol. 16 (2025):1613560.PMID:40822457
- Int Immunopharmacol 165 (2025):115441.PMID:40911993
- J Cell Mol Med 24.7 (2020):4136-4149.PMID:32100443
- Int Immunopharmacol 138 (2024):112625.PMID:38996666
- Food Funct. (2025).
- Int. J. Mol. Sci. 26.9 (2025):4325.
- PLoS Pathog. 21.9 (2025):e1013492.PMID:40920846
- Mol Neurobiol (2024):1-18.PMID:38995443
- Clin Immunol (2024):110308.PMID:39002794
- Bioorg Chem (2025):108926.PMID:40907438
- CANCER CELL INT 25.1 (2025):1-24.PMID:40296031
- Eur J Pharmacol (2025):178123.PMID:40914268
- Transl Oncol 56 (2025):102396.PMID:40239242
- ACS Appl. Nano Mater. (2025).
- Cell Cycle 19.17 (2020):2139-2147.PMID:32779548
- Transl Oncol 47 (2024):102042.PMID:38924847
- J Am Heart Assoc: 14.16 (2025):e040093.PMID:40767292
- T Nonferr Metal Soc 35.8 (2025):2726-2733.
- Cns Neurosci Ther 31.5 (2025):e70437.PMID:40400263
- Int Immunopharmacol 159 (2025):114886.PMID:40424656
- Int Immunopharmacol 138 (2024):112559.PMID:38955028
- Int Immunopharmacol 138 (2024):112539.PMID:38936054
- Am J Physiol-Cell Ph (2024).PMID:39069827
- Food Funct (2025).PMID:40421817
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Front Nutr 12 (2025):1682308.PMID:41112749
- J Dent (2024):105436.PMID:39488296
- Glia (2024).PMID:39610064
- Chem-Biol Interact (2025):111848.PMID:41285280
- Food Funct (2025).PMID:41287971
- Stem Cell Transl Med 14.12 (2025):szaf064.PMID:41325643
- Colloid Surface B (2025):114537.PMID:39879672
- Environ Toxico (2024).PMID:38700384
- Acs Appl Bio Mater (2024).PMID:38700956
- Int Immunopharmacol 163 (2025):115226.PMID:40663811
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Int J Mol Sci 26.13 (2025):5999.
- Toxicology (2024):154018.PMID:39608440
- Biochem Pharmacol (2024):116688.PMID:39617210
- Int Immunopharmacol 162 (2025):115151.PMID:40609203
- Virulence 16.1 (2025):2500493.PMID:40521898
- Bone Joint Res 13.12 (2024):763.PMID:39662502
- Front Cell Dev Biol 12 (2024):1391873.PMID:39170916
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Invest Ophth Vis Sci 66.1 (2025):24-24.PMID:39792075
- Macromol Biosci (2024):2400003.PMID:38597147
- Int Immunopharmacol 147 (2025):113871.PMID:39798467
- Transl Oncol 52 (2025):102256.PMID:39733744
- Int Immunopharmacol 141 (2024):112955.PMID:39163685
- Chem-Biol Interact (2025):111630.PMID:40609922
- Radiother Oncol (2024):110686.PMID:39709027
- Faseb J 38.7 (2024):e23591.PMID:38572579
- J Ethnopharmacol (2024):119272.PMID:39716512
- Life Sci 254 (2020):117793.PMID:32416164
- Drug Des. Dev. Ther. (2025):5123-5141.PMID:40546656
- J Dent (2024):105436.PMID:39488296
- Aging 16.8 (2024):6773-6795.PMID:38643468
- J Ethnopharmacol (2025):120157.PMID:40532799
- J Ethnopharmacol (2024):119073.PMID:39522846
- Nutrients17.20 (2025):3218.
- J Agr Food Res (2025):101694.
- J Ethnopharmacol (2024):118685.PMID:39127116
- Drug Des Dev Ther (2025):281-302.PMID:39845152
- Commun Biol 8.1 (2025):71.PMID:39820362
- Commun Biol 8.1 (2025):1590.PMID:41249558
- Drug Des Dev Ther (2025):5123-5141.
- Acs Biomater Sci Eng (2024).PMID:39164198
- Int Immunopharmacol 168 (2026):115862.PMID:41248570
- Redox Rep 29.1 (2024):2398380.PMID:39284588
- Am J Physiol-Gastr L (2024).PMID:38742280
- Radiother Oncol 203 (2025):110686.PMID:39709027
- Bioorg Chem (2025):109147.PMID:41175726
- J Drug Deliv Sci Tec 104 (2025) 106577.
- J Inflamm Res (2025):7401-7417.PMID:40503490
- Probiotics Antimicro (2025):1-16.PMID:40366615
- Ann Med 57.1 (2025):2523563.PMID:40579858
- Front Pharmacol 16 (2025):1565713.PMID:40474975
- Sci Rep-Uk 14.1 (2024):21680.PMID:39289451
- Environ Toxicol (2023).PMID:37052456
- Biotechnol Genet Eng (2023):1-15PMID:37018431
- Front Pharmacol 15 (2024):1424624.PMID:25956975
- Sci. Rep. 15.1 (2025):15556.PMID:40319036
- Biol 14.6 (2025):594.
- Acs Omega (2025).
- Rsc Adv 13.33 (2023):23010-23020.PMID:37529353
- Bioscience Rep 43.5 (2023):BSR20230028.PMID:37083601
- Biotechnol Genet Eng (2023):1-17.PMID:36946780
- Epigenetics-Us 18.1 (2023):2254976.PMID:37691391
- Mol Cell Biochem (2023):1-11.PMID:36939994
- Poultry Sci (2025):105339.
- Eur J Pharmacol (2024):176995.PMID:39277096
- Oncotargets Ther (2020):2511-2522.PMID:32280236
- Neurochem Res (2023):PMID:37127800
- Spectrochim Acta A 237 (2020):118387.PMID:32416513
- Faseb J39.7 (2025):e70530.PMID:40193045
- Rsc Adv 13.32 (2023):22367-22374.PMID:37497090
- Faseb J 39.2 (2025):e70314.PMID:39825721
- Front Genet 13 (2022):932973.PMID:36118847
- Front Genet 13 (2022):959109.PMID:36147489
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Front Pharmacol 16 (2025):1536091.PMID:40041493
- J Cancer 11.5 (2020):1162.PMID:31956362
- Arch Biochem Biophys (2025):110352.PMID:39978618
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Heliyon 8.11 (2022).PMID:36353164
- Sci Rep-Uk 14.1 (2024):27063.PMID:39511266
- Front Pharmacol 15 (2025):1534772.PMID:39911826
- J Neuro Oncol (2023):1-16.PMID:37351767
- Eur J Pharmacol (2025):177343.PMID:39900330
- Eur J Pharmacol (2025):177497.PMID:40058753
- Arthritis Res Ther 27.1 (2025):12.PMID:39838477
- Front Oncol 14 (2024):1471109.PMID:39582546
- Molecules 30.3 (2025):549.PMID:39942654
- Toxicol Lett 379 (2023):20-34.PMID:36905973
- Brain Res Bull (2025):111245.PMID:39924054
- Sci Rep-Uk 15.1 (2025):794.
- J Endocrinol Invest (2025):1-16.PMID:39786708
- Brain Res Bull (2024):111165.PMID:39667505
- Mol Cells 46.4 (2023):231-244.PMID:36625319
- Front Pharmacol 15 (2024):1453938.PMID:39654626
- J Inflamm Res (2024):10533-10546.PMID:39659750
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Mol Cell Biochem (2025):1-20.PMID:40032749
- Front. Pharmacol. 16 (2025):1545498.
- Metabolomics 20.5 (2024):112.PMID:39369160
- Cell Signal (2025):111815.PMID:40258578
- Front Toxicol 7 (2025):1598185.PMID:40376450
- Bmc Chem 18.1 (2024):1-11.PMID:39396055
- J. Funct. Foods 128 (2025):106822.PMID:39486993
- J. Cell. Mol. Med. 29.8 (2025):e70476.PMID:40275529
- Neuroscience (2023).PMID:37286157
- Front. Oncol. 15 (2025):1536473.PMID:40303992
- Food Chem. Toxicol. (2025):115488.PMID:40288513
- Environ Toxicol (2024).PMID:39400944
- Sci Rep-Uk 15.1 (2025):13282.PMID:40247060
- Ann Transl Med 10.24 (2022).PMID:36660714
- Zool Res 45.5 (2024).PMID:39147715
- Eur J Pharmacol 983 (2024):176995.PMID:39277096
- J Biomed Mater Res A 113.3 (2025):e37893.PMID:40059713
- Mol Cell Biochem (2024):1-15.PMID:39179754
- Cell Death Dis 16.1 (2025):287.PMID:40223081
- Sci Rep-Uk 15.1 (2025):11639.PMID:40185911
- Front Oncol 14 (2024):1440906.PMID:39346724
- Frontiers in Pharmacology 16 (2025):1547685.
- Front Pharmacol 16 (2025):1562839.PMID:40183104
- Front Pharmacol 16 (2025):1517221.
- Bioorgan Med Chem 72 (2022):116994.PMID:36087428
- Bioorgan Med Chem 82 (2023):117234.PMID:36906964
- Zool Res 45.5 (2024):1001.PMID:39147715
- J Cell Mol Med 28.20 (2024):e70163.PMID:39462268
- Sci Rep-Uk 14.1 (2024):25636.PMID:39465338
- Biomedicines 13.6 (2025):1315.PMID:40564034
- Sci Rep-Uk 15.1 (2025):26300.PMID:40683918
- Langmuir 39.39 (2023):14162-14172.PMID:37722015
- Pestic Biochem Phys (2025):106728.
- Bmc Genomics 25.1 (2024):1-13.PMID:38395755
- Food Sci Nutr 13.10 (2025):e71069.PMID:41142018
- J Pharmacol Exp Ther 388.3 (2024):827-845.PMID:38262745
- Cell Signal (2025):112175.PMID:41106751
- Toxicol Appl Pharm 410 (2021):115361.PMID:33285147
- J Cancer 15.5 (2024):1397.PMID:38356722
- J Biochem Mol Toxic 38.1 (2024):e23544.PMID:37815058
- Bmc Complement Med 24 (2024).PMID:38783288
- Endocrine (2024):1-14.PMID:38378893
- Cancer Biol Ther 25.1 (2024):2355705.PMID:38778753
- Sci Rep-Uk 10.1 (2020):20623.PMID:33244088
- Exp Cell Res (2025):114674.PMID:40683587
- Mol Med Rep 31.5 (2025):138.PMID:40145553
- Clin Epigenetics 17.1 (2025):188.PMID:41239389
- Bmc Cancer 22.1 (2022):1-14.PMID:35387643
- J Immunother (2024):10-1097.PMID:38847148
- J Mech Behav Biomed 167 (2025):106963.PMID:40120143
- Oncotargets Ther (2020):11301-11313.PMID:33177838
- J Oncol 2022 (2022).PMID:35518787
- Sci Rep-Uk 14.1 (2024):14438.PMID:38910141
- Cytokine 176 (2024):156507.PMID:38244240
- Endocrine (2024).PMID:38191984
- Poultry Sci (2025):105339.PMID:40482626
- Microb Pathogenesis (2025):107720.PMID:40403987
- Hum Cell 35.4 (2022):1140-1158.PMID:35581525
- J Gen Virol 105.1 (2024):001944.PMID:38180473
- Oncol Res 33.11 (2025):3557.PMID:41179294
- Int J Mol Med 49.3 (2022):1-11.PMID:35014672
- Oral Dis (2024).PMID:38168877
- Am J Transl Res 13.10 (2021):11255.PMID:34786056
- Bmc Complement Med 24.1 (2024):1-16.PMID:38580999
- J Ethnopharmacol 278 (2021):114275.PMID:34087404
- Oncol Rep 46.1 (2021):1-12.PMID:34080652
- Gene (2024):148399.PMID:38518902
- Acta Derm-Venereol 104 (2024).PMID:38590175
- Bmc Cancer 24.1 (2024):465.PMID:38622522
- Transl Oncol 14.12 (2021):101219.PMID:34555726
- Oncol Rep 46.6 (2021):1-12.PMID:34643248
- Toxicol Appl Pharm 422 (2021):115559.PMID:33961903
- J Biochem Mol Toxic 38.4 (2024):e23675.PMID:38488158
- Bmc Cancer 21.1 (2021):1181.PMID:34740322
- Cancer Biol Ther 25.1 (2024):2325126.PMID:38445610
- Acta Diabetol 58.9 (2021):1251-1267.PMID:33907874
- Thorac Cancer 13.5 (2022):761-770.PMID:35098684
- Bmc Cancer 24.1 (2024):1-16.PMID:38475728
- Inflammation 45.1 (2022):372-386.PMID:34792688
- Rsc Adv 14.18 (2024):12864-12872.PMID:38650686
- Toxicol Sci (2024):kfae054.PMID:38636494
- Heliyon (2024).PMID:38707472
- Stem Cell Rev Rep (2025):1-22.PMID:41326923
- Pediatr Res (2024):1-10.PMID:38658662
- Microbiol Spectr (2024):e04142-23.PMID:38421191
- Toxicol Sci 200.1 (2024):146-164.
- Food Sci Nutr 13.11 (2025):e71074.PMID:41169786
- Hypertens Res 45.4 (2022):650-664.PMID:35082376
- Sci Rep-Uk 15.1 (2025):40072.PMID:41249827
- Gerontology (2024).PMID:38168028
- Sci Rep-Uk 15.1 (2025):18697.PMID:40436970
- Food Chem Toxicol (2025):115488.PMID:40288513
- Front Pharmacol 15 (2024):1397761.PMID:39104391
- Brain Res Bull 187 (2022):1-10.PMID:35738501
- Biology 14.9 (2025)
- Metab Brain Dis 38.1 (2023):255-267.PMID:36445630
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Oncol Res 33.8 (2025):2085.PMID:40746890
- Mol Neurobiol (2025):1-20.PMID:40742404
- J Ovarian Res 18 (2025):168.PMID:40731365
- Bmc Genomics 26.1 (2025):706.PMID:40745632
- Mol Immunol 153 (2023):126-134.PMID:36495817
- Bmc Med Genomics 15.1 (2022):1-19.PMID:36503492
- Sci Rep-Uk 15.1 (2025):27517.PMID:40721473
- Bmc Cancer 21.1 (2021):1-15.PMID:34130645
- Neurotox Res 40.6 (2022):1895-1901.PMID:36223054
- Biomed Mater 18.6 (2023):065026.PMID:37852221
- Exp Cell Res (2025):114674.PMID:40683587
- Sci Rep-Uk 15.1 (2025):25039.PMID:40646181
- Sci Rep-Uk 15.1 (2025):24303.PMID:40624204
- Iscience 28.7 (2025).
- Probiotics Antimicro (2025):1-16.PMID:40366615
- J Ethnopharmacol 259 (2020):112956.PMID:32442587
- Aging (Albany NY) 16.14 (2024):11339.PMID:39029955
- Bba-Mol Basis Dis (2024):167467.PMID:39159699
- Sci Rep-Uk 14.1 (2024):18929.PMID:39147857
- Sci Rep-Uk 14.1 (2024):19292.PMID:39164313
- J Steroid Biochem (2023):106429.PMID:38035949
- Sci Rep-Uk 15.1 (2025):30446.PMID:40830225
- Mol Immunol 152 (2022):27-34.PMID:36244215
- Ann Surg Oncol (2025):1-20.PMID:40887570
- ACS Omega (2025).PMID:40686969
- Bba-Mol Basis Dis (2024):167354.PMID:39004378
- Gene (2023):148050.PMID:38042211
- Pharm Biol 60.1 (2022):1436-1448.PMID:35938494
- J Biochem Mol Toxice 36.11 (2022):e23200.PMID:35997646
- J Virol 99.8 (2025):e00498-25.PMID:40631894
- Toxicol Appl Pharm (2023):116794.PMID:38142782
- Oncol Res 33.8 (2025):2085.PMID:40746890
- Eur J Pharm Biopharm (2024):114417.PMID:39013493
- Exp Cell Res (2025):114674.PMID:40683587
- Faseb J 39.16 (2025):e70961.PMID:40827901
- Bba-Mol Basis Dis (2025):168050.PMID:40946874
- J Biol Chem (2024):107499.PMID:38944125
- Metab Brain Dis 37.7 (2022):2349-2362.PMID:35779150
- Poultry Sci (2025):105818.
- Shock 59.3 (2023):426-433.PMID:36609531
- Acta Bioch Bioph Sin 56.5 (2024):776.PMID:38495003
- Bba-Gen Subjects (2024):130628.PMID:38642815
- Gene 932 (2025):148898.PMID:39209182
- Mol Med Rep 28.5 (2023):1-12.PMID:37732544
- Curr Stem Cell Res T 19.7 (2024):1021-1028.PMID:37861049
- J Sci Food Agr (2024).PMID:39394871
- Clin Exp Pharmacol P 50.11 (2023):903-913.PMID:37635387
- Hum Mol Genet (2024):ddae122.PMID:39216871
- Future Microbiol 0 (2024).PMID:38629914
- J Tradit Chin Med 43.4 (2023):744.PMID:37454259
- Mol Biol Rep 51.1 (2024):1-13.PMID:39422836
- Microb Pathogenesis (2024):107055.PMID:39442820
- Cell Transplant 33 (2024).PMID:38334047
- Tissue Cell (2024):102477.PMID:39018712
- Mol Biotechnol (2024):1-15.PMID:38771419
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Chem Biol Drug Des 104.1 (2024):e14580.PMID:39031936
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- J Mol Histol (2024):1-8.PMID:38758519
- Shock (2023):10-1097.PMID:37988072
- Discov Oncol 15.1 (2024):309.PMID:39060620
- Bmc Oral Health 24 (2024):1421.PMID:39574093
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Discov Oncol 15.1 (2024):280.PMID:39004679
- J Orthop Surg Res 18.1 (2023):910.PMID:38031136
- Oncol Res 32.6 (2024):1129.PMID:38827325
- Luminescence 39.1 (2024):e4671.PMID:38286599
- J Mol Neurosci 74.1 (2024):30.PMID:38478195
- Bmc Cancer 24.1 (2024):1-21.PMID:39085784
- N-S Arch Pharmacol (2024):1-21.PMID:39549064
- Biomarkers (2024):1-12.PMID:38568742
- Plos One 20.8 (2025):e0329272.PMID:40758730
- Arch Biochem Biophys 766 (2025):110352.PMID:39978618
- Bba-Mol Cell Biol L 1870.5 (2025):159631.PMID:40379088
- Bioengineered 12.1 (2021):8698-8708.PMID:34697986
- Front Mater 12 (2025):1568591.
- Dis Markers 2022 (2022).PMID:35845132
- Chem Biol Drug Des 105.4 (2025):e70111.PMID:40247760
- Funct Integr Genomic 25.1 (2025):1-17.PMID:40608130
- Mol Carcinogen (2025).PMID:40222040
- Bioengineered 12.1 (2021):5985-5995.PMID:34477479
- Bioengineered 12.1 (2021):6687-6702.PMID:34516362
- J Cancer 16.10 (2025):3048-3064.
- Transbound Emerg Dis 2025.1 (2025).PMID:40692872
- ONCOL LETT 29.6 (2025):1-12
- Bmc Cancer 25.1 (2025):1205.PMID:40707929
- Cell Stress Chaperon 25 (2020):955-968.PMID:32572784
- Cancer Res Commun (2025).PMID:40601866
- Tissue Cell (2025): 102903.
- Mol Carcinogen (2025).PMID:40794014
- Mol Cell Biochem 473 (2020):179-192.PMID:32627113
- Mol. Med. Rep. 31.5 (2025):1-12.PMID:40145553
- Toxicology Letters (2025).PMID:40854414
- Dis Markers 2022 (2022).PMID:35968506
- Andrology-Us (2025).PMID:40862537
- World J Gastro Oncol 17.3 (2025):102187.PMID:40092949
- Virus Res 313 (2022):198748.PMID:35304133
- MED ONCOL 42.4 (2025):1-13.PMID:40072654
- Renal Failure 47.1 (2025):2548613.PMID:40887103
- Plos-One-20.11-(2025):e0336487.PMID:41212870
- RENAL FAILURE 47.1 (2025):2552913.PMID:40898827
- J Appl Toxicol 42.5 (2022):830-840.PMID:34708435
- CURR ISSUES MOL BIOL 47.5 (2025):314.
- Int J Chronic Obstr (2025):623-639.
- Cell Biochem Funct 43.7 (2025):e70097.PMID:40574709
- Exp Eye Res (2025):110492.
- J Orthop Surg Res 20.1 (2025):443.PMID:40319252
- Bioengineered 13.4 (2022):10335-10349.PMID:35435110
- Curr Pharm Biotechno 23.8 (2022):1101-1108.PMID:34463226
- Comput Biol Chem (2025):108540.PMID:40483799
- Carcinogenesis (2025):bgaf030.
- Plos One 20.6 (2025):e0317930.PMID:40455747
- J Integr Complement (2025).PMID:40459144
- Toxicol Lett (2025).PMID:40412772
- Bioengineered 13.3 (2022):6807-6818.PMID:35246020
- Bioengineered 13.3 (2022):6650-6664.PMID:35230214
- Chem Biol Drug Des 99.6 (2022):828-838.PMID:35184389
- Bioengineered 13.5 (2022):11987-12002.PMID:35603556
- METABOLITES 15.5 (2025):290.
- J Mol Neurosci 72.2 (2022):433-440.PMID:35023001
- Bioengineered 13.1 (2022):455-468.PMID:34967265
- Mol Biotechnol 64.12 (2022):1367-1375.PMID:35639278
- Bioengineered 13.1 (2022):1518-1529.PMID:34986734
- Bosn J Basic Med Sci 20.3 (2020):357.PMID:31733641
- Microvasc Res (2025):104833.PMID:40571189
- Dis Markers 2022 (2022).PMID:35845132
- Microb Pathogenesis (2025):107720.PMID:40403987
- Kaohsiung J Med Sci (2025):e70031.PMID:40387410
- J ORTHOP SURG RES 20.1 (2025):443.PMID:40319252
- Bioengineered 12.2 (2021):11451-11460.PMID:34895055
- Bioengineered 12.2 (2021):11936-11946.PMID:34784841
- Biochem Bioph Res Co (2025):151972.
- CURR DRUG DELIV (2025).PMID:39976030
- Exp Eye Res (2025):110492.PMID:40541914
- J Mech Behav Biomed (2025):106963.
- J Pharm Pharmacol 71.9 (2019):1412-1420.PMID:31282010
- Front Med-Lausanne 11 (2025):1534120.PMID:39882536
- Pathol Res Pract (2025):156247.PMID:41045764
- J Pharm Pharmacol (2025):rgaf094.PMID:41042989
- Bmc Pregnancy Childb 25.1 (2025):1001.PMID:41034826
- Chem Biodivers (2025):e00918.PMID:40991575
- Tissue Cell 80 (2023):102001.PMID:36565506
- Pathogens 14.2 (2025):182.
- Int J Chronic Obstr (2023):919-932.PMID:37229441
- Mol Biol Rep 52.1 (2025):212.PMID:39921807
- Luminescence 40.2 (2025):e70116.PMID:39914999
- Aesthet Plast Surg (2025):1-15.PMID:40180642
- Eur Rev Med Pharmaco 23.5 (2019).PMID:30915737
- Toxicol-Lett-(2025).PMID:40854414
- Planta Med 89.05 (2023):493-507.PMID:35716667
- Technol Cancer Res T 19 (2020).PMID:33111613
- Shock (2023):10-1097.PMID:37179246
- Molecular brain 18.1 (2025):1-23.PMID:39962509
- Curr Issues Mol Biol 47.5 (2025):314.PMID:40699713
- Clinics 77 (2022).PMID:35662010
- Integr Cancer Ther 24 (2025).PMID:40944546
- Plos One 19.12 (2024):e0316362.PMID:39724098
- FEBS Open Bio 12.1 (2022):146-153.PMID:34644456
- Int J Chronic Obstr (2025):623-639.PMID:40092321
- Heliyon (2024):.PMID:37461802
- S Afr J Bot 177 (2025):445-456.
- N S Arch Pharmacol (2023):1-13.PMID:37160483
- Toxicol Appl Pharm (2025):117264.PMID:39952301
- Toxicon X (2025):100236.
- Eur J Med Res 30.1 (2025):54.PMID:39865289
- Cell Mol Biol Lett 24.1 (2019):1-14.PMID:31889958
- Toxicon (2025):108293.PMID:39999927
- Pathogens 14.2 (2025):182.
- Thorac Cancer 14.9 (2023):815-826.PMID:36737402
- Mol Brain 18.1 (2025):1-23.PMID:39962509
- Luminescence 40.2 (2025):e70095.PMID:39924164
- Pharmacology 108.2 (2023):166-175.PMID:36724745
- Int J Biochem Cell B (2025):106880.PMID:41265698
- Mol Med Rep 31.3 (2025):1-10.
- Toxicol Appl Pharm (2025):117639.PMID:41232729
- Toxicol Appl Pharm (2025):117232.PMID:39832565
- Genomics (2025):111009.PMID:39864635
- Brain Res (2025):149942.PMID:40930451
- Mol Cell Biochem 476 (2021):1387-1400.PMID:33389498
- EXP LUNG RES 51.1 (2025):79-92.PMID:40889519
- Cell J 24.1 (2022):15.PMID:35182060
- Exp Ther Med 20.4 (2020):3290-3300.PMID:32855700
- Vet Parasitol 331 (2024):110284.PMID:39126893
- Women's Health Reports 6.1 (2025):803-815.
- Asian J Urol (2025).
- J Int Med Res 49.3 (2021).PMID:33730930
- Biochem Bioph Res Co (2025):153108.PMID:41386101
- Transl Cancer Res 14.5 (2025):2594.PMID:40530117
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Curr Cancer Drug Tar 24.9 (2024):975-986.PMID:38204265
- J Interf Cytok Res (2025).PMID:40512525
- Chin J Integr Med (2024):1-11.PMID:38941045
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Biochem Bioph Res Co (2025):152196.PMID:40516308
- Hematology 30.1 (2025):2523082.PMID:40611540
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Oncol Lett 30.606 (2025).
- Transplant Direct 11.7 (2025):e1829.PMID:40590007
- Immunobiology (2024):152832.PMID:38943814
- J Int Med Res 48.4 (2020).PMID:31891283
- Vet Parasitol (2024):110284.PMID:39126893
- Adv Clin Exp Med 30.10 (2021):1031-1041.PMID:34329545
- Biochem Bioph Res Co (2025):152500.PMID:40858065
- J Obstet Gynaecol Re PMID:39169658
- J Asian Nat Prod Res 24.11 (2022):1078-1085.PMID:34935551
- Oncol Lett 30.6 (2025):606.PMID:41181631
- Oncol Lett 29.6 (2025):276.PMID:40247989
- Cell Mol Biol 70.2 (2024):161-168.PMID:38430026
- Peerj 13 (2025):e19550.PMID:40611940
- Pathol Res Pract 217 (2021):153284.PMID:33249400
- Andrologia 2025.1 (2025):4092625.
- J Integr Complement (2025).PMID:40459144
- Pediatr Surg Int 40.1 (2024):63.PMID:38431920
- Translational Cancer Research 14.8 (2025).PMID:40950680
- Toxicon 257 (2025):108293.PMID:39999927
- Peerj 13 (2025):e19550.PMID:40611940
- Immunobiology (2025):153090.
- Pediatr Surg Int 39.1 (2022):54.PMID:36534156
- Int J Gen Med (2022):3199-3213.PMID:35342302
- N S Arch Pharmacol (2023):1-13.PMID:37052642
- Chin J Integr Med (2025):1-10.PMID:40338446
- Cell Mol Biol 69.12 (2023):223-231.PMID:38063090
- Open Life Sci. 20.1 (2025):20221056.
- AESTHET PLAST SURG (2025):1-15.PMID:40180642
- Ann Hepatol 27.4 (2022):100700.PMID:35338010
- Discov Oncol 14.1 (2023):1-10.PMID:37907650
- Bmc Nephrol 24.1 (2023):314.PMID:37884904
- TRANSL ANDROL UROL 14.2 (2025).PMID:40114844
- PeerJ 13 (2025):e19083.
- J Int Med Res 48.4 (2020).PMID:31891283
- Anim Biotechnol (2023):1-12.PMID:36756956
- Acta Histochem 125.8 (2023):152097.PMID:37813066
- J Membrane Biol 253 (2020):43-55.PMID:31820013
- J Toxicol Sci 48.8 (2023):469-479.PMID:37532580
- Balk Med J 41.6 (2024).PMID:39319820
- Vet Microbiol (2025):110495.
- Genes Genom (2023):1-15.PMID:37318704
- Oncol Res 33.1 (2024):103.PMID:39735676
- World J Oncol (2024):.
- Anticancer Res 43.8 (2023):3411-3418.PMID:37500147
- Comb Chem High T Scr (2024).PMID:35894460
- Clin Hemorheol Micro (2023):1-15.PMID:37212088
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- Hematology 28.1 (2023):2220522.PMID:37272581
- Am J Transl Res 14.10 (2022):6964.PMID:36398260
- Balk Med J 41.6 (2024):491.PMID:39319820
- Am J Transl Res 15.7 (2023):4873.PMID:37560235
- Bmc Pediatr 25.1 (2025):42.PMID:39825267
- Cell J 25.8 (2023):554.PMID:37641417
- Biochem Genet (2023):1-18.PMID:37148331
- Curr Mol Pharmacol 17.1 (2024).PMID:36946474
- Mol Cell Probe (2025):102031.
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Aesthet Plast Surg (2023):1-11.PMID:38148357
- Biochem Bioph Res Co (2025):152196.PMID:40516308
- Cancer Biomark 42.5 (2025):18758592241306263.
- J Obstet Gynaecol Re PMID:39169658
- Cell J 24.1 (2022):15.PMID:35182060
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Particul Sci Technol (2025):1-13.
- Neuroreport 33.10 (2022):413.PMID:35623086
- Fitoterapia (2024):106245.PMID:39393711
- Endocr Metab Immune 24.1 (2024):153-162.PMID:37150983
- Iran J Immunol (2023).PMID:37865874
- J Cancer Metas Treat (2024).
- J Herbs Spices Med P (2025):1-16.
- J Cardiothorac Surg 20 (2025):270.PMID:40555993
- Nat Prod Commun 20.10 (2025).
- Transpl P 52.1 (2020):398-405.PMID:31928781
- Neurol Res (2025):1-14.PMID:41117931
- Transl Cancer Res 13.4 (2024).PMID:38737693
- Jove-J Vis Exp 220 (2025):e68581.
- Medicine 104.41 (2025):e45095.PMID:41088697
- J Craniofac Surg 33.4 (2022):1250-1254.PMID:36041089
- Crit Rev Eukar Gene (2025).
- J Cardiothorac Surg 20.1 (2025):53.PMID:39794868
- Front Oncol 10 (2020):387.
- Int J Bioprinting (2024).
- J Hazard Mater (2024) 135735.
- Biomedicines 12.11 (2024):2543.
- New J Chem 48.11 (2024):5068-5073.
- J Pharm Sci 75.10 (2020):505-509.PMID:33305726
- Front Pharmacol 15 (2024):1384141@0.jpg
- Green Process Synth 13.1 (2024):20240050.
- Bioact Mater 36 (2024):524-540.
- BioRxiv (2025):2025-06.
- Phytother Res 34.4 (2020):836-845.
- Int J Biol Sci 20.12 (2024):4713-4730.
- J Funct Foods 123 (2024):106621.
- J Transl Med 22.1 (2024):1-16.
- J Nutr Biochem (2024):109769.PMID:9276944
- Front Pharmacol 15:1453938.
- bioRxiv (2025):2025-08.
- Netw Model Anal Hlth 13.1 (2024):1-15.
- Faseb J 38.15 (2024):e23876.
- bioRxiv (2025):2025-08.
- Bioact Mater 43 (2025):32-47.
- Adv Funct Mater 29.50 (2019):1906690.
- Cell Biomaterials (2025).
- BioRxiv (2025):2025-06.
- Phytomedicine (2024):156091.
- bioRxiv (2025):2025-01.
- Int J Mol Sci 25.19 (2024):10339.
- Am J Cancer Res (2024):2852-2867.
- Diss. University of Kansas, 2025.
- Heliyon (2024).
- Drug Des Dev Ther (2024):5841-5851.
- J Integr Med-Jim (2024).
- Mol Ther-Nucl Acids (2020).
- Int J Mol Sci 25.19 (2024):10496.
- Carbohyd Polym (2024):122897.
- Viruses 16.8 (2024):1239.
- Seoul University Graduate Schoo2025.
- Small (2024):2402308.PMID:3911
- Acs Appl Mater Inter (2024).PMID:39167710
- Acta Pharmacol Sin 44.1 (2023):255-257.PMID:35773339
- BioRxiv (2025):2025-01.PMID:39975379
- Am J Chinese Med (2025):1-20.PMID:40646505
- Mater Res Express 7.2 (2020):025401.
- Drug Resist Update (2024):101161.
- Biosens Bioelectron (2024):116875.
- Int J Mol Sci 25.15 (2024):8340.
- Bioorg Chem (2024):107731.
- Bioact Mater 44 (2025):220-235.
- Heliyon (2024).
- Mol Ther Nucl Acids (2020).
- J King Saud Univ Sci 32.7 (2020):2912-2919.
- scienceasia (2024).
- ACS Appl. Eng. Mater. (2025).
- J Hazard Mater (2024):136113.
- Biomed Pharmacother 179 (2024):117370.
- Biol 14.7 (2025):780.PMID:40723340
- Drug Dev Res 81.4 (2020):437-443.PMID:31904108
- Pharmaceuticals-Base 17.10 (2024):1295.
- Mater Express 10.1 (2020):102-111.
- J Transl Med 22.1 (2024) 1-16.
- Gene (2024) 149056.
- Ecotox Environ Safe 286 (2024):117233.
- bioRxiv (2024) 2024-10.
- hLife (2024).
- Antioxidants-Basel 13.11 (2024):1289.
- bioRxiv (2025):2025-08.
- Rev Bras Farmacogn (2024):1-7.
- Antioxidants 13.11 (2024) 1320.
- Toxins 16.7 (2024):319.
- Int J Mol Sci 25.20 (2024):11184.
- Front Bioeng Biotech 12 (2024):1460870.
- J Pharm Anal (2024):101053.
- Nutrients 16.14 (2024):2314.
- Nutrients 16.14 (2024):2346.
- Acs Omega (2024).
- Acs Appl Nano Mater (2024).
- Heliyon (2024).
- Indian J Pharm Sci 86.3 (2024).
- J Tradit Compl Med (2024).
- Chem Eng J (2024):156542.
- Cell Biomaterials (2025):
- Transl Cancer Res 13.4 (2024).
- Int J Mol Sci 21.21 (2020):8095.PMID:33142980
- Ann Hematol (2023):1-12.
- J Oncol 2022 (2022).PMID:36059813
- Molecules 27.16 (2022):5337.PMID:36014573
- Cancers 14.19 (2022):4645.PMID:36230568
- Food Sci Nutr (2023).
- Phytother Res 37.2 (2023):477-489.PMID:36199227
- Pharmaceutics 14.10 (2022):2157.PMID:36297592
- Biomaterials Advances 142 (2022):213165.PMID:36341744
- Biocell 47.8 (2023).
- Cancers 14.21 (2022):5218.PMID:36358640
- J Agr Food Chem 70.44 (2022):14220-14234.PMID:36300841
- Int J Mol Sci 23.16 (2022):9014.PMID:36012290
- Cells 11.22 (2022):3580.PMID:36429010
- Mol Cell Toxicol (2022):1-11.
- Crit Rev Eukar Gene 34 (2024).
- Histol Histopathol 35.9 (2020):919-927.PMID:32282924
- Vaccines-Basel 11.11 (2023):1678.PMID:38006011
- Front Immunol 14 (2023).PMID:37901236
- Acs Appl Bio Mater 6.1 (2023):74-82.PMID:36603189
- Int J Mol Sci 24.19 (2023):15003.PMID:37834451
- Mater Today Chem 27 (2023):101331.
- Viruses 14.8 (2022):1783.PMID:36016405
- Pharmaceutics (2023) 15(12):2713.
- Int J Mol Sci 24.2 (2023):1243.PMID:36674761
- Transl Cancer Res 11.6 (2022):1781.PMID:35836521
- Acta Trop 232 (2022):106519.PMID:35584779
- Cytotechnology 74.3 (2022):421-432.PMID:35733701
- Sensors & Diagnostics (2024).
- Phytomedicine (2024):155347.
- Phytomedicine 103 (2022):154199.PMID:35679793
- Adv Funct Mater (2024):2305827.
- Foods 11.11 (2022):1575.PMID:35681325
- Oxid Med Cell Longev 2022 (2022).PMID:35770048
- Mater Today Adv 15 (2022):100271.
- Carbohyd Polym 295 (2022):119878.PMID:35989018
- Int J Biol Sci 20.2 (2024):433-445.PMID:37379961
- Phytomedicine 105 (2022):154330.PMID:35905566
- J Oncol 2022 (2022).PMID:35909906
- Oxid Med Cell Longev 2022 (2022).PMID:35936222
- Adv Funct Mater (2023):2309690.
- Oncol Rep 51.2 (2024):1-13.PMID:38131250
- Biomed Pharmacother 170 (2024):116042.PMID:38118351
- Dis Markers 2022 (2022).
- Int J Gen Med (2023):5817-5839.PMID:38106976
- Discov Oncol 13.1 (2022):71.PMID:35941331
- Biochip J (2023):1-10.
- Exp Ther Med 25.2 (2023):1-10.PMID:PMID_36684652
- Clin Transl Disc 2.2 (2022):e49.
- J-Ethnopharmacol 318 (2024):116969.PMID:37516391
- Ceram Int 49.15 (2023):25953-25963.
- Colloid Surface B 228 (2023):113364.PMID:37290201
- Oncol Lett 26.1 (2023):1-17.
- Biocell 47.8 (2023).
- Vaccines Basel 11.7 (2023):1190.PMID:37515006
- Adv Funct Mater (2023):2214998.
- Poultry Sci 102.10 (2023):102946.PMID:37542939
- Cancer Res Commun 2.6 (2022):471-482.PMID:36338546
- Acs Appl Polym Mater 4.10 (2022):7014-7024.
- Int Immunopharmacol 123 (2023):110709.PMID:37515849
- Cell Mol Biol 69.5 (2023):44-50.PMID:37571902
- Crystals 13.7 (2023):1067.
- bioRxiv (2022):2022-04.
- Appl Entomol Zool 58.4 (2023):303-313.
- Aging (Albany NY) 15.12 (2023):5713PMID:37390121
- Front Mar Sci 9 (2022):861117.
- Nanophotonics 11.22 (2022):5089-5100.
- Front Microbiol 14 (2023).PMID:37645224
- ACS omega 8.30 (2023):27146-27155.PMID:37546678
- Iscience 26.9 (2023).PMID:37670789
- J Thorac Dis 15.4 (2023):2198.PMID:37197522
- Chem Eng J 474 (2023):145358.
- Pharmaceuticals-Base 16.10 (2023):1482.PMID:37895953
- Mol Med 29.1 (2023):6.PMID:36647009
- Mol Cell Toxicol (2023):1-10.
- Aquaculture 564 (2023):739060.
- Drug Develop Res 84.2 (2023):312-325.PMID:36658741
- Sensor Actuat B-Chem 381 (2023):133437.
- Trop J Pharm Res 22.9 (2023):1857-1862.
- Trop J Pharm Res 22.9 (2023):1779-1784.
- Sensor Actuat B Chem 394 (2023):134396.
- Int J Mol Sci 24.21 (2023):15545.PMID:37958531
- Poultry Sci 102.4 (2023):102511.PMID:36805396
- Oxid Med Cell Longev 2023 (2023).PMID:36778205
- Curr Issues Mol Biol 45.5 (2023):4017-4034.PMID:37232725
- Mol Cell Oncol 10.1 (2023):2238873.PMID:37649964
- Int J Pept Res Ther 29.2 (2023):19.
- Microorganisms 11.9 (2023):2258.PMID:37764102
- Int J Mol Sci 24.7 (2023):6279.PMID:37047251
- J Inflamm Res (2023):1045-1057.PMID:36936349
- View-China 4.2 (2023):20220052.
- J-Ethnopharmacol 318 (2024):116961.PMID:37541404
- Int J Nanomed (2023):5423-5440.PMID:37767196
- bioRxiv (2023):2023-05.PMID:37292976
- Exp Ther Med 26.5 (2023):1-15.PMID:37869642
- Int J Mol Sci 25.2 (2024):919.
- Front Cell Infect Mi 12 (2022):423.PMID:35573770
- Chin Herb Med (2024).
- Applied Sciences 14.8 (2024):3186.
- Front Cell Neurosci 15 (2021):569424.PMID:33815059
- Open Med-Warsaw 16.1 (2021):558-569.PMID:33869778
- Phytomedicine 86 (2021):153565.PMID:33945919
- Pharmaceuticals-Base 17.4 (2024):515.
- Cells 13.9 (2024):728.
- Mol Biotechnol 63.8 (2021):686-693.PMID:33977498
- Compos Part B-Eng 220 (2021):108984.PMID:35988999
- Diabet Metab Synd Ob (2021):2255-2268.PMID:34045875
- Acs Appl Bio Mater 4.6 (2021):5026-5032.
- Adv Funct Mater (2024):2402663.
- Front Cell Dev Biol 8 (2021):568304.PMID:33763412
- Exp Eye Res 209 (2021):108642.PMID:34058232
- Acs Pharmacol Transl (2024).
- Heliyon (2024).
- J Inflamm Res 14 (2021):2445.
- HemaSphere 5.7 (2021).PMID:34136753
- Cancer Manag Res (2021):4709-4723.PMID:34163246
- Acs Appl Opt Mater (2024).
- Redox Biol (2024):103143.
- Food Hydrocolloid 120 (2021):106980.
- Biomaterials 272 (2021):120757.PMID:33798960
- J Biol Chem 297.2 (2021).PMID:33722608
- J Agr Food Chem (2024).
- Phytomedicine (2024):155767.
- Acs Omega (2024).
- Talanta (2024):126381.
- Mol Cell Biochem (2024) 1-13.
- J Cancer 15.13 (2024):4244-4258.
- Nat Commun 15.1 (2024):4969.PMID:38862489
- Bladder 12.2 (2025):e21200036.PMID:40747461
- Heliyon (2024).
- Int J Biol Macromol 307 (2025).PMID:40112979
- Pharmaceutics 16.6 (2024):744.
- Molecular Therapy Oncology (2024).
- Front Pharmacol 11 (2021):618262.PMID:33551818
- Theranostics 14.7 (2024):2687.
- Anal Cell Pathol 2020 (2020).PMID:33354489
- Front Pharmacol 15 (2024):1389976.
- Available at SSRN 4830418.
- Phytomedicine (2024):155744.
- bioRxiv (2024):2024-05.
- Adv Funct Mater (2024):2400489
- Plos Pathog 19.4 (2023):e1011305.PMID:37053288
- Phytomedicine (2024):155656.
- Nanoscale (2024).
- J Clean Prod 315 (2021):128201.
- Front Pharmacol 13 (2022):899775.PMID:35571096
- J Ethnopharmacol (2024):117867.PMID: 38342155
- Transl Cancer Res 11.1 (2022):206.PMID:35261897
- Tissue Cell 76 (2022).PMID:35182988
- Front Immunol 15 (2024):1326137.
- Pharmacol Res 177 (2022):106112.PMID:35122955
- Nano Today 43 (2022):101416.
- Antioxidants Basel 13.3 (2024):264.
- New J Chem (2024).
- Kaohsiung J Med Sci (2024).PMID:38340032
- Bba-Mol Cell Biol L 1867.6 (2022):159137.PMID:35247568
- Front Oncol 12 (2022):851300.PMID:35392243
- Phytochem Lett 47 (2022):174-179.
- J Biomed Nanotechnol 20.1 (2024):133-142.
- Front Immunol 15 (2024):1347683.PMID:38343537
- Oncol Lett 23.5 (2022):1-8.PMID:35350588
- J Cancer 13.6 (2022):1808.PMID:35399733
- Bioengineered 13.4 (2022):9145-9155.PMID:35363601
- bioRxiv (2024):2024-02.
- Mater Today Bio (2024):100958.
- Int J Mol Sci 23.8 (2022):4128.PMID:35456945
- Cell Death Dis 15.1 (2024):97.PMID:38286802
- J Funct Foods 114 (2024):106076.
- Mater Design (2024):112812.
- Oxid Med Cell Longev 2021 (2021):1-30.PMID:34257808
- Cells 10.9 (2021):2399.PMID:34572049
- Appl Entomol Zool (2022):1-14.
- J Inflamm Res 14 (2021):3523.PMID:34335041
- Fiber Polym (2022):1-9.
- Biomed Res Int 2021 (2021).PMID:34373837
- Dis Markers 2021 (2021):1-12.PMID:34413913
- New J Chem 48.11 (2024):5068-5073.PMID:PMID
- Nanomaterials 11.8 (2021):2008.PMID:34443839
- Int J Mol Sci 22.16 (2021):8898.PMID:34445601
- Exp Ther Med 27.5 (2024):1-16.
- Nano Res (2022):1-8.
- Bio-Des Manuf 5.2 (2022):358-370.
- Phytochem Lett 46 (2021):79-89.
- J Environ Pathol Tox 42 (2023).PMID:36749091
- Fitoterapia (2024):105884.
- Eur J Med Chem (2024):116323.PMID:(2024) 116323.
- Carbohyd Polym 277 (2022):118869.PMID:34893274
- PeerJ 9 (2021):e11482.PMID:34820154
- Tissue Cell 74 (2022):101680.PMID:34808429
- Nano Today 41 (2021):101326.
- Exp Ther Med 23.2 (2022):1-9.PMID:35069838
- Exp Ther Med 23.2 (2022):1-9.PMID:35069839
- Int J Mol Sci 25.24 (2024):13439.
细胞计数试剂盒-8(CCK-8)使用WST-8(2-(2-甲氧基-4-硝基苯基)-3-(4-硝基苯基)-5-(2,4-二磺酚基)-2H-tetrazolium,单钠盐),在存在电子载体1-Methoxy PMS的情况下,产生水溶性福尔马定染料进行方便的测定。 CCK-8溶液直接加入到细胞中,无需预先混合组分。 WST-8被细胞脱氢酶生物还原为可溶于组织培养液的橙色福尔马定产物。 产生的福尔马定量与活着的细胞数量成正比。由于CCK-8溶液非常稳定且具有很小的细胞毒性,因此可以进行更长时间(例如24至48小时)的孵育。
细胞计数试剂盒 - 8允许灵敏度高、用于增殖和毒性测定中确定存活细胞数量的显色法检测。 检测灵敏度比MTT、XTT或MTS等任何其他四唑盐都要高。

图1:Cell Counting Kit-8(CCK-8)的工作机制。
细胞数量确定
1.将细胞悬浮液(100μL/孔)接种在96洞孔板中。将板在潮湿的培养箱中预孵育(例如,在37℃,5%CO2下)。
2.向板的每个孔中加入10μLCCK8溶液。注意不要在孔洞中引入气泡,因为它们会干扰O.D.读数。
3.将培养板在培养箱中孵育1-4小时。
4.使用酶标仪测量450 nm处的吸光度。
细胞增殖和细胞毒性测定
1.将种子细胞以103-104个细胞/孔的密度在96孔板中在100μL培养基中培养。将细胞在CO2培养箱中于37℃培养24小时。
2.将不同浓度的待测物质加入板中。
3.将培养板在培养箱中孵育适当的时间(例如,6,12,24或48小时)。
4.使用重复移液器向板的每个孔中加入10μLCCK8溶液。注意不要在孔洞中引入气泡,因为它们会干扰O.D.读数。
5.将培养板在培养箱中孵育1-4小时。
6.在读取孔板之前,重要的是在轨道振动器上轻轻混合1分钟,以确保颜色均匀分布。
7.使用酶标仪测量450 nm处的吸光度。
数据分析
统计分析有几种方法,您可以选择使用O.D.值或细胞数量,我们提供其中一种方法。
细胞存活率(%)= [(As-Ab)/(Ac-Ab)]×100
抑制率(%)= [(Ac-As)/(Ac-Ab)]×100
As =实验孔吸光度(含有细胞,培养基,CCK-8和待测化合物的孔的吸光度)。
Ab =空白孔吸光度(含有培养基和CCK-8的孔的吸光度)。
Ac =对照孔吸光度(含有细胞,培养基和CCK-8的孔的吸光度)。
制作标准曲线
1. 细胞计数板计数细胞悬液中的细胞数。
2. 使用培养基,等比稀释细胞悬液为一个浓度梯度,通常需要5-7个浓度梯度,每组几个复孔。然后接种细胞。(注意每孔的细胞数量。如果您将细胞悬液稀释在管中,在加入培养板的孔之前,请小心再次混匀细胞。每孔中细胞悬液的体积应该是一致的。)
3. 培养直至细胞贴壁(通常2-4小时),然后每100 μl培养基加入10 μl CCK-8。继续孵育1-4小时,用酶标仪测量450nm处的吸光度。制作出一条以细胞数为X轴坐标,O.D.值为Y轴坐标的标准曲线。
可以基于该曲线确定待测样品的细胞数。使用此标准曲线的先决条件是培养检测条件相同。
注意事项
1. 确保药物和CCK8均匀分布在培养基中。
2. 细胞增殖越多, 颜色越深; 细胞毒性越强,颜色越浅。
3. 对于贴壁细胞,每孔至少需要1000个细胞(100 μl培养基)。对于白细胞,由于灵敏度较低,每孔至少需要2500个细胞(100 μl培养基)。推荐的96孔板每孔最大细胞数为25000。如果使用24孔或6孔板进行该检测,请计算相应的每孔的细胞数,并调整CCK-8的体积,使其为每孔总液体体积的10%。
4. 因为CCK8测定是基于活细胞中的脱氢酶活性,影响脱氢酶活性的条件或化学物质可能导致实际活细胞数与使用CCK-8测定活细胞数之间有差异。
5. WST-8可能与还原剂反应生成WST-8 formazan。如果使用还原剂 (例如一些抗氧化剂)会干扰检测。如果待检测体系中存在较多的还原剂,需设法去除。
6. 孵育2小时后,背景O.D.值一般为0.1-0.2单位。
7. 注意不要在孔中引入气泡,因为它们会干扰O.D.值。
8. 如果您想对CCK8溶液进行灭菌,请使用0.2 μm的膜过滤溶液。
9. 孵育时间因孔中细胞的类型和数量而异。通常,白细胞着色较弱,因此可能需要较长的孵育时间(长达4小时)或大量细胞(~105细胞/孔)。
10. 如果细胞悬液中存在高浊度, 测量并减去样品在600nm或更高波长的O.D值。
11. CCK8不能用于细胞染色。
12. 培养基中的酚红不会影响实验结果,酚红的吸光度可以在计算时,通过扣除空白孔中本底的吸光度而消去,因此不会对检测造成影响。
13. CCK8的毒性非常低,在CCK8测定完成后,相同的细胞可用于其他细胞增殖测定,例如结晶紫测定,中性红测定或DNA荧光测定。(除非细胞极为稀少,不推荐。)
14. 该试剂盒可用于大肠杆菌,但不能用于酵母细胞。
15. 在读取平板之前,您可以在摇床上轻柔混匀。
16. 我们建议将细胞接种在靠近培养板中央的孔中,最外围一圈孔中的培养基容易蒸发,可以用PBS,水或培养基填充这些孔。
17. 如果您没有450nm滤光片。您也可以使用吸光度在430和490nm之间的滤光片, 450nm滤光片具有最佳灵敏度。
18. 测量450nm处的吸光度,如果您需要进行双波长测定,作为参考波长可以测定650nm处的吸光度。
19. 药物中金属离子的存在可能会影响CCK8的灵敏度。终浓度为1mM的氯化亚铅、氯化铁、硫酸铜会抑制 5%、15%、 90% 的显色反应,使灵敏度降低。如果终浓度是10mM的话,将会100%抑制。
常见问题
Q:如何做空白对照?
A:可以用加相应量细胞培养基和CCK-8但不加细胞的孔作为空白对照,若担心所使用的药物会干扰检测,需设置加相应量细胞培养液、药物和CCK-8但不加细胞的孔作为空白对照。
Q:只加CCK-8不加细胞的空白孔,数值上增?
A:在整个实验过程中,随着时间的增加,如果细胞培养时间较长,请注意蒸发问题。因为反应环境温度较高,会有部分液体挥发。空白组虽然没有细胞,但是随着液体的挥发,药物浓度相当于提高了,所以空白对照的数值也会有轻微的变化(但不会有明显的变化)。如果很在意空白对照的数值,可将96孔板外围一圈加培养基、水或PBS 保湿。同时,可以把96孔板置于培养箱内靠近水盘的位置以缓解蒸发。将96孔板外围两圈用PBS铺板,这样挥发先挥发周边的,可以对内部及空白对照的影响降至最低。
Q:一般多久测一次值?
A:预实验时可以在0.5、1、2和4小时后分别用酶标仪检测,然后选取吸光度范围比较适宜的一个时间点用于后续实验。
Q:加入CCK8后暂时不测OD值,可以如何处理暂时保存?能够保存多久?
A:如果需要暂时不测定OD值,可以向每孔中加入10ul 0.1M HCl溶液或者1% w/v的SDS溶液,避光保存在室温,24小时内吸光度不会发生变化。
Q:如何保存?
A:CCK-8溶液在避光、0-5℃的条件下可以保存1 年,若长期不用可在-20℃下避光保存2年。建议分装后保存于-20℃,使用时提前于4℃解冻,请避免反复冻融,否则增加背景值,干扰实验结果。
Q:是否需要更换培养基?
A:不需要,若药物影响比较小的情况可以不更换培养基,直接扣除培养基中加入药物后的空白吸收即可。
Q:待测物质有氧化性或还原性该做何处理?
A:本试剂盒的检测依赖于脱氢酶催化的反应,如果待测物质有氧化性或还原性,可在加CCK-8之前更换新鲜培养基,去掉药物的影响。
如果实验中有还原剂,请检查背景的OD值,即在不含细胞的培养基中加入药物,然后加入CCK-8试剂在一定时间内检测,和不加药物的培养基进行比较(只有CCK-8试剂),如果O.D值明显偏高,则说明有反应。
Q:如果培养基颜色或PH已变化,是否需要更换新的培养基?
A:加入CCK-8时,如果细胞培养时间较长,培养基颜色或pH值已变化,建议换用新鲜的培养基。
Q:适用细胞?
A:因为测线粒体酶,所以真核细胞,有线粒体的均可,例如单细胞,动物细胞。但有细胞壁的细胞,例如植物细胞,酵母细胞,底物进入细胞效率低,不推荐。
Q:线性不佳原因?
A:细胞不均;培养液蒸发;还原剂;气泡;孔板周围一圈不能用,除非只培养少于一天的时间;细胞数目很重要,太少信号会低。
Q:金属毒性?
A:可以检测金属毒性,最好做空白对照。
Q:适用于那些细胞?其他还有哪些细胞可用?生物被膜内的活菌 (流感嗜血杆菌和绿脓杆菌)?
A:所有哺乳动物的细胞,细菌一般没有检测CCK8的,可以染色法,或者流式,最常规的方法,有报道, 比浊法测OD600。
Q:是否可以替代Brud或EDU法检测细胞增殖?
A:虽然CCK8通过检测对生长期的细胞内的脱氢酶来反应细胞的活性,而胸腺嘧啶插入法通过核苷酸类似物的方式插入合成的DNA来检测细胞的活性,这几种方法是有一定关联性的,CCK8可替换胸腺嘧啶插入法来检测细胞增殖,并且检测更方便。
Q:空白孔数值偏高,有可能是培养基长菌吗?或者其他原因?
A:空白孔数值偏高一般认为染菌造成的,很少出现这种问题。
Q:CCK8能检测组织吗
A:不能检测组织。
Q:是否可以检测T细胞
A:可以,T细胞长的慢,需延长孵育时间。
Q:当两个细胞混合培养时(骨髓间充质细胞,另一个是悬浮T细胞),培养一段时间后,只测骨髓间充质干细胞的生长、增殖情况,请问用CCK-8能测吗?怎么做?
A:对于两种细胞的情况:
1)如果测定贴壁细胞的生长状况,那么可以把悬浮的T细胞转移掉,使用上述第二种方法测定。
2)如果T细胞对于间充质细胞的生长很关键,不能取走,那么测定的活性程度是总量,此时,需要对每一个孔的T细胞进行估算,如果每个培养条件下T细胞总量接近,或者T细胞含量很少,远远小于间充质细胞,也可以测定,使用对照孔可以去除T细胞的影响。
3)如果T细胞可以短时间内除去,可以找个灵敏度高的CCK-8,信号强,建议细胞量合适的情况下(每一个孔10000个),30分钟左右出读数结果,测 定后,可以将T细胞再加入培养孔。 这样做对细胞的生长影响不大。但是如果做动力学,那么要考虑的因素多一些。
Q:CCK-8是通过和细胞内的脱氢酶反应而反映着细胞数量,假如细胞已经死亡,而脱氢酶活性还有,那么如何计算细胞数量?
A:多数情况下,细胞死亡过程中,细胞内的成分会降解,脱氢酶会有部分释放,但是活性和活细胞比,比较低。举例说:100个细胞死亡20小时后,释放的脱氢酶活力,不足5个活细胞的脱氢酶活力,也就是说,这种情况带来的误差5%以内。而且,这种细胞死亡,对同种细胞来说,情况是一样的,一般都是在不同的孔间比较同种细胞,所以系统误差是一样的,即系统误差会彼此消减。
| 应用&特点 |
1) 细胞增殖测定 - GlpBio细胞计数试剂盒-8(CCK-8)是水溶性的,在培养中是稳定的,并且是无毒的。 2) 细胞活力测定 - 代谢活性和染料产生与改变的活力成比例地变化。 3) 细胞因子测定 - 测量细胞因子诱导的增殖。如果需要,可以在研究结束时回收细胞并扩增。 4) 细胞毒性测定 - 来自细胞毒性化学物质的细胞死亡对颜色发展没有影响,只有活细胞将试剂转化为比色指示剂。试剂本身具有可忽略的毒性,并且通常对细胞是安全的。 |
| 运输方式 | 蓝冰运输。 |
| 储存条件 | 储存在4°C避光,可稳定长达12个月。储存在-20°C避光,可稳定长达2年。 |
| 用途 | 仅供研究使用!不能用于人体。 |
| CCK-8 | MTT | MTS | SRB |
| Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
| Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
| Character | Liquid | Solid | Liquid | Liquid |
| Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
| Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
| Convenience | +++ | ++ | +++ | + |
| Detection speed | +++ | + | ++ | + |
| Repeatability | +++ | + | ++ | ++ |
| Stability | ++ | + | + | +++ |
-
Related Biological Data

Therapeutic targeting of the DDR1–NF-κB–NRF2 axis inhibits PDAC growth and metabolism. a, Parental and E79Q KPC cells plated on wild-type or R/R ECM were incubated in LG medium with or without 7rh, ML120B or ML385. Total viable cells are presented relative to parental cells that were treated with vehicle and plated on wild-type ECM.
Cell viability was determined with a Cell Counting Kit-8 assay (Glpbio).
Nature 610.7931 (2022): 366-372. PMID: 36198801 IF: 69.5026 -
Related Biological Data

LIG1 reversed cell proliferation, apoptosis and DNA damage effects of hsa_circ_0007919 (A-B) CCK-8 analysis of the proliferation of GEM-resistant PDAC cells with or without LIG1 inhibition.
EIPA , IPI549, MBQ-167, MRT68921 or erlotinib, ML385, HCQ or their combinations were added to the wells for 24, 72 or 96 hrs. Next, 10 uL of CCK-8 (GlpBio) was added to each well.
Cancer Cell (2021). PMID: 33740421 IF: 38.5836 -
Related Biological Data

Effect of CrEL on glucose transport.Cell Counting Kit-8 (CCK-8) is a fluorescent glu-cose analog. INK-128 (mTORi) was used as a control for de-creased glucose transport.
Cells after transfection or GEM treatment were collected and counted, then 4 × 103 cells were placed into 96-well plate and cultured in incubator at 37°C. 24, 48, 72 and 96 h after, cells were incubated with 100 μl serum-free medium and 10 μl CCK-8 solution (Glpbio, USA) at 37°C for 2 h and measured at 450 nm wavelength.
Molecular Cancer, 2023, 22(1): 195. PMID: 38044421 IF: 37.2999 -
Related Biological Data

Bifidobacterium cultural supernatant and I3C protected mice against ALF. (G-H) Primary hepatocytes were pre-treated with or without I3C for 1 h followed by PBS or APAP administration for 12 h. The effects of I3C on CCK8 (G) and LDH (H) were detected. n=3-5.
Cell counting kit 8 (CCK8) experiment for in vitro assay were performed using the CCK8 Kit (Glpbio, Cat# GK10001, USA) according to the manufacturer's instructions.
Cell Host & Microbe 32.1 (2024): 48-62. PMID: 38056458 IF: 30.3013 -
Related Biological Data

Fe3O4@IR820@CpG induces immunogenic cell death and promotes DC maturation in vitro. A,B) Viability of MC38 cells after incubation with A) different concentrations of Fe3O4@IR820@CpG without laser irradiation or B) different formulations with 808 nm laser irradiation (1 W cm−2) for 5 min, as detected by CCK-8 kit (n = 4).
Bicinchoninic Acid Assay (BCA) protein assay kit,cell counting kit-8 (CCK-8), and erythrocyte membrane lysates were purchased from GlpBio (Montclair, USA).
Advanced Materials, 2023: 2307193. PMID: 37951210 IF: 29.4006 -
Related Biological Data

H) The viability ofMC38 cells treated with PAD@MS for 48 h in the presence or absence of 10 μM Ferr-1, 20 μM Nec-1, 10 μM z-VAD-FMK, and 1 mM NAC.
Cell viability was detected by cell counting kit-8 (CCK-8) assay (GlpBio, USA) according to the manufacturer’s instruction.
Adv Funct Mater, 2023: 2214998. IF: 19.9246 -
Related Biological Data

After transfection with si-1 and si-2, performed CCK-8 assays were performed to evaluate the cellular growth curves and the results revealed that repressing the expression of PCAT6 remarkably suppressed the cell proliferation of HeLa and SiHa cells.
Each well was added with 10 μl CCK-8 reagent (GLPBIO, Montclair, CA, USA) and the plates were continued to be cultured for 1-2 h. The cell viability was determined by measuring the optical density (OD) absorbance at the wavelength of 450 nm.
Eur Rev Med Pharmacol Sci.2019 Mar;23(5):1947-1956 -
Related Biological Data

Blocking bFGF leads to decrease in cell proliferation and clone formation of cisplatin (DDP) selected A549 cells. Growth curves showed that knocking down bFGF expression resulted in reduction in cell proliferation.
The cells were incubated for 24 h in incubator, and then,10μl CCK-8 (GLPBIO) was added in every well and cultivated at room temperature for 4 h. Absorbance was measured at 450 nm. The experiment repeated three times successive 7 days.
J Pharm Pharmacol.2019 Sep;71(9):1412-1420.